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Abstract
Patients with Parkinson’s disease (PD) are thought to be selectively impaired in
consciously-mediated online automatic motor control, whereas the ability to perform
subconscious online adjustments remains intact. This present study evaluates the hypothesis
that the previously alleged deficits in online motor control in PD are not due to the
consciousness of the correction, but rather are attributable to aspects of the prior
experimental designs disproportionately penalizing patients for PD-related bradykinesia.
Here, we implemented a modified traditional double-step paradigm to investigate
consciously-mediated online motor control in PD, in a manner that would be unconfounded
by disease-related bradykinesia. Further, we investigated the effects of dopaminereplacement therapy on performance. We found that PD patients (n=12) and healthy-matched
controls (n=12) were equal in performing automatic online corrections whether or not these
corrections were consciously perceived, and their performance was unaffected by
dopaminergic therapy. These findings inform our understanding of automatic motor control
in PD.

Keywords
Online Motor Control; Parkinson’s Disease; Automaticity; Perception; Bradykinesia;
Dopaminergic Therapy
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Chapter 1: Introduction
1.1 Summary of Online Motor Control
Fast and precise modifications to motor plans can be implemented while actions are
occurring (i.e. online). This flexibility with respect to predefined motor plans is incredibly
adaptive. Continuous real-time supervision of an ongoing movement is achieved through
feedback loops comparing the limb and goal positions. Through this mechanism, motor error
signals can be generated and adjustments in limb position can be promptly induced in
response to changing task demands, such as when the target location changes, or simply
when the initial motor plan is imperfect (Bard et al., 1999; Desmurget et al., 1999; Gréa et
al., 2000).
Evidence validating the rapid online control of action has primarily stemmed from the
use of a behavioral task known as the ‘double-step’ paradigm. In this experimental design,
participants are instructed to point to a peripheral visual target, which depending on the trial,
will either remain stationary or will unexpectedly change locations at hand movement onset.
These target perturbations rapidly induce changes in limb trajectory away from its original
path and toward the new goal location. Such unexpected target displacements provide a
valuable opportunity to investigate how planned actions are adapted in real-time following
their initiation.

1.1.2 Psychophysics of Online Corrections
Accurate and rapid online motor control relies heavily on the multisensory fusion of
visual, proprioceptive, and vestibular modalities, as well as fast internal feed-forward and
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feedback loops (Prablanc et al., 1979; Todorov & Jordan, 2002). To fully understand the
mechanisms involved in online corrections, it is first important to break down the
psychophysics of pointing movements directed at stationary targets.
Neurophysiological studies have identified a latency of 60-100 ms between the overt
eye movement response and the overt arm movement response in a standard peripheral
pointing task (Desmurget et al., 2001; Johnson-Frey, 2003; Prablanc & Martin, 1992).
Ultimately, this delay translates into the gaze arriving at the target at approximately the same
time as hand movement begins. However, it is critical to note that the initial EMG discharge
for the eye and the hand is nearly synchronous (Biguer et al., 1982; Jeannerod, 1988).
Increased latencies for the arm compared to the eye are reasoned to be attributable to
increased inertial forces, rather than an actual delay in sensorimotor processing. This serial
organization of the ocular-motor response helps explain how and why actions are modified
online. In contrast to traditional theories of motor control, the hybrid model of online motor
control posits an integrated two-step process (Desmurget & Grafton, 2000; Hoff & Arbib,
1993; Pélisson et al., 1986; Prablanc & Martin, 1992). First, a crude motor program for the
arm, based on perifoveal information, is generated prior to limb movement onset. Given that
this initial motor command is generated based on an imperfect approximation of the target
position, it might only function to rapidly drive the effector into the general vicinity of the
target. Once the primary ocular saccade has reached the target, the arm movement begins.
Thus, to refine the action and optimize control, the arm’s motor plan can be automatically
updated online, after movement initiation, based on the new and improved foveal
information.
Similarly, in the context of the ‘double-step’ paradigm, the central nervous system
will continue to parse the visual scene and integrate novel information in accordance with
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unexpected changes in task demands. In-flight modifications can be derived from a predictive
feed-forward model of where the limb position should be relative to the target (Wolpert et al.,
1995), to avoid inherent delays associated with sensory processing. When there is an
unexpected change in target position, there will be a significant disparity between the actual
and predicted sensory outcome of an ongoing action. An error signal will be detected and
translated into a motor command aimed at adapting patterns of muscle activation to minimize
the discrepancy. These adaptations in muscle activity proceed in a similar manner for doublestep movements as they do for single-step movements. Changes in EMG activity occur
approximately 100 ms after target perturbation and such EMG bursts precede actual
deviations in limb kinematics (Fautrelle et al., 2010). It is through feed forward specification
of motor commands and continuous feedback loops that the motor system is able to generate
online corrections within ~150 ms of target displacement (Brenner & Smeets, 1997;
Gritsenko et al., 2009; Izawa & Shadmehr, 2008; Paulignan et al., 1991; Prablanc & Martin,
1992; Soechting & Lacquaniti, 1983). Such rapid, real-time adjustments far surpass the
temporal rates associated with sensory processing alone, which can often exceed ~250 ms
(Frith et al., 2000).

1.1.3 Automaticity of Online Corrections - ‘The Automatic Pilot’
Over the last few decades, accumulating evidence has prompted the online corrective
system to be notably referred to in the literature as the hand’s ‘automatic pilot’. A variety of
studies support the notion that online corrections involve little if any conscious iterative
control (Day & Lyon et al., 2000; Diedrichsen et al., 2004; Johnson et al., 2002; McIntosh et
al., 2010; Pisella et al., 2000). Online modifications in reach trajectories have been shown to
occur well before the time at which the participant reports consciously perceiving these
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adaptations. For example, Castiello et al. (1991) showed that limb trajectories could be
modified within 120 ms of target perturbations – whereas it took participants greater than 400
ms to vocalize their conscious perception of the target jump. This lag was interpreted to
reflect an inherent delay between action and perception, rather than simply an increase in the
time needed to generate a vocal response. Moreover, it is well accepted that limb
modifications can occur even in the absence of a conscious awareness of both one’s own
reach amendments and/or perturbations in target position. That is to say, the hand can be
guided to a new target position regardless of any conscious perceptual awareness of the
change and independent of intention. This has best been studied through the use of Goodale
et al.’s (1986) modification of the traditional double-step design. Here, instead of a target
perturbation being elicited at hand movement onset, a small target displacement was
triggered while the participant performed their initial eye movement to the first appearing
target. Although participants lacked a conscious awareness of the target being displaced, their
hand trajectories appropriately diverged away from their original path to reach the new target
position, without any additional delay. It was suggested that the participants’ failure to
perceive the second target displacement reflected the naturally occurring ‘fine-tuning’ of the
human ocular system. Primary saccades often undershoot a target’s position and require the
refinement of a subsequent corrective saccade to accurately bring the target of interest
directly onto the fovea. Therefore, triggering a relatively small target displacement (~10% of
the movement amplitude) during the primary saccade would induce the same post-saccadic
refinement as would occur in a single-step trial. The apparent correction that would occur due
to the target perturbation would simply reflect that which normally follows a primary saccade
to a stationary target in any case. Other groups have since replicated these findings and have
suggested that errors can still be efficiently corrected by the motor system, even when these
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errors are not consciously perceived by the participant (Chua & Enns, 2005; Desmurget et al.,
2001; Pelisson et al., 1986; Prablanc & Martin, 1992). These results not only lend support for
the automaticity of this corrective response, but also suggest that separate neural pathways
might mediate perception and action (Milner & Goodale, 1995).
The notion that double-step-induced online corrections are largely automatic is also
supported by studies finding comparable limb movement durations (MD) in reaching to
targets that remain stationary versus to targets that moved to a final location while the action
was underway. Namely, this online response mechanism results in the participant taking the
same amount of time to point to a stationary target as it does for them to point to a target that
ends in the same location, although its initial position had been different when the reaching
movement was started. Thus, while limb trajectories are being modified to reach a new target
position, no additional processing time is required. As alluded to earlier, this rapid processing
indicates that the corrective system might be able to bypass the typical time course required
for an afferent sensory signal to be translated into an efferent motor command. Furthermore,
these findings suggest that a new motor command is not being completely reprogrammed,
but rather online corrections induce rapid automatic modulations of the ongoing response and
motor programme.
Although the consensus is that rapid, online corrections suggest a certain level of
automatic processing, the degree to which these processes operate automatically remains less
known. To address this knowledge gap, researchers have compared the corrective system
against two additional standards required for highly automatic processes. First, the action
should be fairly insensitive to conscious iterative control. That is, online corrections should
function as ‘hard-wired’ processes that cannot be easily overridden. Compliance with this
criterion has best been demonstrated in studies where participants are instructed to abort their
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pointing action upon detection of a target displacement. Most notably, Pisella et al. (2000)
demonstrated in a significant number of trials that regardless of their intention to do so,
participants were unable to successfully interrupt their online correction. Furthermore, follow
up studies have since modified Pisella et al.’s (2000) design by instructing participants to
point in the opposite direction of a target jump, rather than inhibit or cancel their action
outright. Comparably, participants were unable to repress motor corrections and reliably
deviated their trajectory in the direction of the target jump despite the anti-point instruction
(Day & Lyon, 2000; Johnson et al., 2002).
The second criterion for automaticity states that the action must remain unaffected by
simultaneous cognitive load. A typical way to investigate this is through the use of a dualtask paradigm, in which participants are asked to perform two simultaneous tasks.
Performing an action during single versus dual task conditions can be compared to
investigate the efficiency and automaticity of the action. An automatic action should be
performed equivalently under single or dual task conditions. Using this approach, Liu et al.
(2008) demonstrated that a simultaneous object identification task interfered with the
planning of an action, but not the online control of an already initiated action. Consequently,
it was argued that whereas competing cognitive resources might disrupt the pre-programming
of an action, online control of an already established action remains unaffected. McIntosh et
al. (2010) further corroborated these findings by showing that both the speed and accuracy of
online corrections are unaltered by the simultaneous performance of an auditory 1-back task.
Collectively, these results have led to conclusions ascribing an extremely high level of
automaticity and autonomy to online reach corrections.
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1.1.4 Neural Substrates Involved in Online Motor Control
In addition to inputs from the extrastriate visual cortex, the posterior parietal cortex
(PPC) receives input from a variety of other sensory modalities including the auditory and
somatosensory regions (Fogassi & Luppino, 2005). The PPC’s neuroanatomical connectivity
and its integrative role concerning spatial representations of the body and target objects in the
environment render it a prime candidate for specifying online context-dependent motor
commands (Andersen et al., 1997). Despite the large body of evidence supporting the PPC as
a well-positioned and likely component of online motor control, less is known about the
exact nature of the underlying mechanisms mediating its involvement in rapid online motor
adjustments. The strongest direct evidence comes from studies in patients with PPC lesions
who exhibit significant impairments in double-step reaching tasks compared to single-step
tasks. Desmurget et al. (1999) first reported disturbances in in-flight reach adjustments upon
transcranial magnetic stimulation (TMS) of the left posterior parietal lobe. Similarly,
MacDonald and Paus (2003) reported that the awareness of self-generated movements was
disrupted when repetitive TMS was applied over the superior parietal lobe. These results
have since been supplemented by a clinical case study of a patient with ischemic bilateral
parietal lesions. This patient demonstrated selective impairments during a double-step
pointing task requiring online reach adjustments, while retaining the ability to accurately
point to stationary targets during a single-step condition (Pisella et al., 2000). More recently,
Battaglia Mayer et al. (2013) found similar disturbances in reach adjustments upon
deactivation of the parietal areas through the injection of gamma-aminobutyric acid (GABA)A agonists in non-human primates.
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In line with these results, neurophysiological studies have also identified changes in
PPC activity 150 ms following target displacement and approximately 20 ms prior to changes
in hand kinematics (Archambault et al., 2009; Archambault et al., 2011). Similarly, in a
positron emission topography (PET) study, increased activity in the intraparietal sulcus was
found during a double-step pointing task when compared to a single step task in which no
online corrections were required (Desmurget et al., 2001). Taken together, the anatomical
positioning and neurophysiological results have led researchers to hypothesize a fundamental
role for the PPC as a “neural comparator” in online movement guidance. In this regard, the
PPC might integrate sensory inflow and motor outflow, thereby computing the motor error
between the target position and the predicted location of the hand. The PPC identifies to what
extent the existing motor command is imprecise and how this error can be rectified through
forward modelling of limb dynamics (Buneo & Andersen, 2006; Desmurget et al., 1999;
Gréa et al., 2002).
Whereas the PPC is thought to be involved in identifying error signals, the anterior
parasagittal cerebellar cortex is argued to be involved in converting these signals into
corrective motor commands (Desmurget et al., 2001). Anatomical studies have identified a
range of diverse connections between the cerebellum and cortical areas, including parietal,
temporal, motor, and premotor cortices (Ramnani, 2006). It is through these connections that
the anterior parasagittal cerebellar cortex generates an accurate corrective motor plan in
response to the neural signals issued by the primary motor cortex. Subsequently, changes in
muscle activation can be induced to redirect the limb in-flight to a modified trajectory path
(Bastian et al., 1996; Day et al., 1998; Desmurget et al., 2001). Additionally, a strong line of
evidence implicates the cerebellum in the feed-forward prediction of sensory consequences
of movements (Blakemore et al., 2001; Miall et al., 1993). Congruent with these theories, a
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PET imaging study showed increased activity of the anterior parasagittal cerebellar cortex
following unexpected disturbances in target position requiring inflight reach amendments
(Desmurget et al., 2001).
More recently, sub-cortical structures, including the basal ganglia, have been
implicated in online motor control. The basal ganglia are a collection of subcortical nuclei,
including the striatum as the input region, and the globus pallidus and substantia nigra
reticularis (SNr) as the output regions, which have been extensively implicated in motor and
cognitive functions (Blandini et al., 2000; DeLong, 2000; Graybiel, 2000; Parent & Hazrati,
1995). Scarce support for the basal ganglia in online motor control has primarily stemmed
from clinical studies investigating patients with basal ganglia disorders, such as Huntington’s
disease (HD) and Parkinson’s disease (PD). Smith et al. (2000) first reported that patients
with HD have a diminished capacity to adapt their actions online in response to large,
externally applied perturbations to their moving limb. It is important to note that in addition
to basal ganglia degeneration, HD patients also suffer from significant cortical atrophy,
which makes interpretation of their data difficult (Ciarmiello et al., 2006; Hedreen et al.,
1991; Rosas et al., 2008). In contrast, studies in early PD are more specific tests of basal
ganglia involvement in online motor control, given a significant and specific biochemical
deficit to the striatum, compared to relative sparing of the cortex (Halliday et al., 2011;
Hornykiewicz, 1998; Jellinger, 1991). Currently, to our knowledge, few studies have
reported PD-related impairments in iterative online motor control in response to both target
errors and execution errors (Desmurget et al., 2004; Tunik et al., 2004). The role of the basal
ganglia in online motor control is further complicated by inconsistent results from
neuroimaging studies. Diedrichsen et al. (2005) revealed increased striatal (i.e., putamen and
caudate nuclei) activity exclusively during online corrections induced by target
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displacements, whereas no such elevation in striatal activity was reported for execution errors
induced by mechanical limb perturbations. In contrast, other groups reported augmented
basal ganglia activity only during the ‘pre-movement’ planning phase of self-initiated
actions, as opposed to during the online execution of the action itself (Elsinger et al., 2006;
Boecker et al., 2008). Furthermore, clinical reports speculate that the basal ganglia are
involved in striatal-dopamine-mediated correction of trial-to-trial errors. The ambiguous use
of the term “error correction” has perhaps resulted in unwarranted support for the basal
ganglia in the automatic control of the in-flight error corrective system. Critically, Smith &
Shadmeh (2000) have highlighted that it is essential to distinguish between the different
mechanisms for adjusting to errors online compared to adapting to errors identified through
trial-to-trial learning. Second, reports cite that patients with PD not only use visual feedback,
but might actually rely more heavily on this visual information during reaching or pointing
tasks. Increased reliance on continuous visual information might be an alternative strategy
used to help compensate for PD-related deficits in the pre-programming of a motor plan
(Flash et al., 1992; Klockgether et al., 1994). In theory, if the basal ganglia are truly
implicated in online control, then dysfunction of this neural region should significantly
disturb the use of visual feedback loops during an ongoing action. In subsequent chapters, I
will further elaborate on online motor control in PD, along with the myriad of factors that
possibly confound interpretation of previous work that has supported impairments in this
function in this disease.
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1.2. Parkinson’s Disease
1.2.1 Parkinson’s Disease Pathology & Aetiology
PD is the second most common neurodegenerative disorder worldwide. A central
pathological change in PD, giving rise to its most recognizable motor symptoms, comprises
the substantial degeneration of dopaminergic neurons in the substantia nigra pars compacta
(SNc) and, to a much lesser extent, in the ventral tegmental area (VTA). To understand the
neuropathology of PD, it is first important to review normal basal ganglia circuitry. The basal
ganglia are a collection of sub-cortical nuclei situated at the base of the prosencephalon. The
striatum is the principal input structure of the basal ganglia, receiving afferent projections
from virtually all functioning regions of the cerebral cortex, the thalamus, the SNc and the
VTA. Cortico-striatal connections are functionally and topographically divided and provide
excitatory glutamatergic input to the striatal medium spiny neurons (MSNs). In turn, the
MSNs project to the two major output components of the basal ganglia, the globus pallidus
and the SNr, through a direct and indirect pathway respectively. The striatal output of both
pathways is inhibitory, with GABA being the principal neurotransmitter of the output
streams. The pallidal complex and the SNr, in turn, provide inhibitory outputs to the
thalamus, which then projects back, via excitatory connections, to the cortex. The direct and
indirect basal ganglia pathways have antagonistic effects on thalamic and thus, target cortical
structures. Excitation of the direct pathway results in net excitation of thalamic neurons,
whereas excitation of the indirect pathway results in net inhibition of thalamic neurons
(Alexander et al., 1986; Gerfen, 1996; Graybiel, 2000; Gurney et al., 2001; Haber, 2003;
Haber & Calzvara, 2009; McHaffie et al., 2005; Parent, 1990; Parent & Hazrati, 1995). The
thalamus has excitatory connections to the cortex and in this way the direct pathway
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enhances cortical activity whereas the indirect pathway depresses it. Connectivity of the
indirect and direct pathways is illustrated in Figure 1.

Figure 1. Model of Normal Basal Ganglia Circuitry. Neurons expressing D1class dopamine receptors form the excitatory direct striatonigral pathway, whereas
neurons expressing D2-class dopamine receptors form the inhibitory indirect
striatonigral pathways. The output of the basal ganglia is dependent on the balance
between both the direct and indirect pathways. Solid lines represent excitatory
projections and dashed lines represent inhibitory projections. Adapted from Lewis
et al. (2003).
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The direct and indirect basal ganglia pathways are modulated through dopaminergic
striatonigral projections. Critically, there is differential expression of D1 and D2-class
dopamine receptors in each of these two streams. MSNs in the direct pathway have high
levels of D1-class receptors, which depolarize the neuron in response to dopamine. In
contrast, the MSNs in the indirect pathway predominately express D2-class receptors, which
hyperpolarize the neuron in response to dopamine. The functional antagonism between D1
and D2-class receptors translates into heightened dopamine levels stimulating the direct
pathway, while simultaneously inhibiting the indirect pathway. Together, increased striatal
dopamine results in an overall reduction in GPi and SNr activity and consequently an overall
increase in thalamic and cortical activity (DeLong et al., 2007; Graybiel, 2000; Smith et al.,
1998; Utter & Basso, 2008).
An appropriate balance between both the direct and indirect basal ganglia pathways is
integral for proper psychomotor functioning. When this balance is interrupted, discharge
patterns in the basal ganglia become abnormal and movement disorders prevail. In the case of
PD, the SNc suffers the greatest dopaminergic neuron loss compared to other basal ganglia
nuclei (Fahn, 2003; Greenfield & Bosanquet, 1953; Jellinger, 1991; Tanner & Goldman,
1996). Degeneration of the striatonigral dopaminergic pathway increases neuronal activity in
the GPi and the SNr, and consequently results in over-inhibition of thalamo-cortical and
brainstem motor systems (Transm, 1995). The hallmark features of PD – including poverty of
voluntary movements and resting tremor – are primarily owed to excessive inhibition of these
neural regions.
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1.2.2 Symptomology of Parkinson’s Disease
Striatal dopamine depletion leads to the predominant motor features of PD, including
early bradykinesia, rigidity, resting tremor, as well as later postural and gait abnormalities.
These early, main motor characteristics almost always present unilaterally at onset, though
they eventually become bilateral with disease progression. Bradykinesia refers to slowness in
movement and often occurs in conjunction with reduced spontaneous and hypometric
movements, termed akinesia or hypokinesia. Bradykinesia can manifest as increased motor
reaction times (RT), decreased acceleration, and reduced movement velocities. Such
movement abnormalities have been suggested to arise due to a central deficit in the planning
phase of motor control (Berardelli et al., 2001). In other words, deficits in pre-programming
of motor plans are postulated to produce difficulties initiating movements and maintaining
consistent force and speed (Sheridan et al., 1987).
Although primarily characterized by motor symptoms, non-motor symptoms are also
commonly present in PD and include neuropsychiatric (Aarsland et al., 1999; Aarsland et al.,
2009; Chaudhuri et al., 2009), cognitive (Dubois & Pillon, 1996; Green et al., 2002;
Jankovic, 2008; Owen et al., 1992), autonomic (Goetz et al., 1986; Wakabayashi &
Takahashi, 1997), gastrointestinal (Edwards et al., 1992; Pfeiffer, 2003), sensory, (Ansari &
Johnson, 1975; Snider et al., 1976; Ward et al., 1983;) and sleep disturbances (Comella,
2003; Menza et al., 2010). The most prevalent neuropsychiatric complaints include
depression (McDonald et al., 2003; Slaughter et al., 2001; Reijnders et al., 2008), anhedonia
(Isella et al., 2003), apathy (Pluck & Brown, 2004) and anxiety (Richard et al., 1995; Stein et
al., 1990).
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1.2.3 Symptomatic Treatment of Parkinson’s Disease
Currently, there is no cure for PD. Dopamine replacement therapy replenishes
dopamine in the striatum, alleviating motor and some cognitive impairments. Oral
administration of L-3, 4-dihydroxyphenylalanine (levodopa), a precursor to dopamine,
remains the primary treatment of choice. Levodopa is decarboxylated after passing through
the blood brain barrier, enabling it to act directly on dopamine receptors within the brain.
Commonly, levodopa is administered in conjunction with peripheral decarboxylase
inhibitors, such as carbidopa, to prevent the decarboxylation of levodopa to dopamine prior
to crossing the blood brain barrier.
Despite the known efficacy of levodopa in improving certain motor symptoms, its
effects on cognitive functions have proven to be somewhat paradoxical. Increasingly,
levodopa has been recognized to improve certain domains, while impairing functioning in
others. Such inconsistent findings have been attributed to uneven dopaminergic cell depletion
across the SNc and VTA respectively. The SNc, which innervates the dorsal striatum (i.e.,
bulk of caudate nuclei and putamen), experiences profound dopaminergic neuron loss. In
contrast, the VTA, which innervates the ventral striatum (i.e., nucleus accumbens, ventral
putamen and ventral caudate), remains relatively spared from such cell death (Fearnley &
Lee, 1991; Goto et al., 1989; Hirsch et al., 1988). Therefore, dopamine replacement
therapeutics might help restore dopamine levels in depleted neural regions like the dorsal
striatum, but might detrimentally ‘overdose’ less affected neural regions such as the ventral
striatum. Accordingly, functions mediated by the dorsal striatum, such as cognitive flexibility
and motor control, are thought to improve with dopaminergic therapy (Cools & D’Esposito,
2011; Robbins & Everitt, 1992), whereas certain cognitive tasks, such as probabilistic
associative learning and impulsive responding, mediated by VTA-innervated brain regions
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are thought to become impaired (Cools et al., 2001; Jahanshahi et al., 2010; MacDonald &
Monchi, 2011). That is, overdose effects in PD could be due to exogenous dopamine therapy
distributing to relatively dopamine replete brain regions (i.e., those innervated by VTA) as
well as to intended regions that are significantly dopamine depleted (i.e., mainly dorsal
striatum innervated by SNc). Nevertheless, these findings do not clarify whether these
changes in performance are due to a main effect of dopamine medication or if they are due to
a PD by medication interaction. To circumvent this ambiguity, the effect of levodopa on
performance in healthy controls, who presumably have optimal baseline levels of
endogenous dopamine, has been investigated (Cools & Esposito, 2011; Flöel et al., 2005;
Rihet et al., 2002; Shellshear et al., 2015; Vo et al., 2015). Such an experimental
manipulation allows the effects of dopaminergic medication to be investigated in a way that
is unconfounded by PD-related pathology. Moreover, it helps facilitate our understanding
surrounding the effects of excessive ventral striatal dopamine.

1.2.4 Online Motor Control in Parkinson’s Disease
Although it is well established that PD disrupts certain motor domains, especially
those associated with the pre-programming of a movement (Harrington & Haaland, 1991),
far less is known about how patients with PD control actions that are underway. To the best
of our knowledge, surprisingly few studies have directly examined online motor control in
PD. Tunik et al. (2004) developed a postural trunk-perturbation paradigm, in which controls
and patients with PD were instructed to touch their finger to their nose while their trunk
position was unexpectedly perturbed. Unexpected perturbations in trunk position required the
participants to adapt their upper-limb motor plans to smoothly and accurately complete the
finger-to-nose action. Here, they found that PD patients were significantly impaired in the
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perturbed trunk condition, as revealed by these patients having segmented trajectory paths,
increased MDs, and irregular velocity profiles. The authors interpreted these findings as
evidence that basal ganglia dysfunction leads to deficits in the flexibility of responses to
amended motor states.
Critically, the neural correlates and mechanisms for adjusting to “execution errors”
and “target errors” are distinct. Despite both errors inducing similar online corrective
responses, they rely on fundamentally different computational strategies (Diedrichsen et al.,
2005). As such, one should be hesitant to compare these results to those of online corrections
to visual targets, as is assessed using a double-step paradigm. Indeed, in a traditional doublestep experiment, PD patients did not demonstrate any deficits in adjusting their hand
trajectories in response to subliminal, small target jumps occurring during their initial
saccades (Desmurget, 2004). In contrast, in a separate follow up experiment, Desmurget et al.
(2004) showed that although PD patients could consciously perceive a target displacement,
they failed to adequately modify their ongoing trajectories when that target’s location was
largely displaced at hand movement onset. These two findings guided the current
interpretation that whereas PD patients are impaired in consciously-mediated automatic
online motor control, they retain the ability to perform subconscious automatic online motor
adjustments.
Critically, a finding of impaired automatic online processing in PD directly
contradicts the predominant notion that the dorsal striatum is responsible for suppressing
automatic behavioral responses. That is, the current literature suggests that dysfunction of the
dorsal striatum leads to increased interference from salient stimuli and consequently greater
automaticity in behavioral responses (Benke et al., 2003; Cameron et al., 2010; Cools et al.,
2006; Cools et al., 2010; Rieger et al., 2003; Thoma et al., 2008). During cognitive
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assessments, such as the Stroop task, PD patients reveal a greater tendency to perform the
automatic response of reading the word rather than the more cognitively controlled response
of naming the color (Brown & Marsden, 1988; Dujardin et al., 1999; Henik et al., 1993).
Likewise, using a stop-signal paradigm Rieger et al. (2003) showed increased stop signal RTs
in patients with striatal lesions relative to their control counterparts, indicating a role of the
striatum in the volitional control of an ongoing response. These results are further
corroborated by functional magnetic resonance imaging (fMRI) paradigms, which have
demonstrated greater dorsal striatal activity in conditions with increased interference (Ali et
al., 2010; Liu et al., 2010). For instance, dorsal striatal activity has been shown to increase
when participants are required to provide a less-practised or less automatic response, such as
naming a picture in their second language relative to their first language (Liu et al., 2010).
Moreover, these findings extend to psychophysical paradigms, such as the anti-saccade task,
which instructs participants to look in the opposite direction of an appearing visual stimulus.
This paradigm requires participants to not only supress the automatic pro-saccade, elicited by
the external visual stimulus, but also generate a volitional saccade via an internal command.
Unsurprisingly, PD patients commonly demonstrate robust impairments in this task, as
indicated by increased RTs and a greater inability to suppress pro-saccades in the direction of
the target (Briand et al., 1999; Kitagawa et al., 2004; Van Koningsbruggen et al., 2009). In
contrast, in pro-saccade tasks that instruct participants to look towards the sudden appearing
target, participants with PD perform this automatic orienting response normally (Briand et al.,
1999;) and in some cases even better than controls (Armstrong et al., 2002; Chan et al.,
2005). Although, the effects of consciousness have yet to be directly investigated on
automatic action in PD, results from the Stroop task and pro-saccade task indicate that
automatic function can in fact rely on consciously perceivable visual cues. Consequently, the
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finding that patients with PD are impaired at online automatic motor control when
adjustments are conscious is not expected from the literature.
In light of this broader literature, the finding by Desmurget et al. (2004) that PD
patients were impaired in automatic online motor corrections, when the need to perform a
correction was consciously perceived, was somewhat unforeseen. On further consideration,
aspects of Desmurget’s experimental setup, unrelated to the consciousness of the corrective
action, might have differentially impacted PD patients’ performance relative to that of their
control counterparts. In particular, in the experiment where the need for a corrective action
became consciously perceived, the timing of the target jump was linked to movement onset.
Bradykinesia, a cardinal motor symptom, causes PD patients to take longer to initiate actions.
Therefore, when target perturbations occurred at movement onset, this target jump and
change in the movement trajectory would occur later for PD patients compared to their
controls. PD patients would therefore have an increased time to prepare their movement
toward the initial target position. That is, PD patients would exhibit an increased preparatory
phase to plan their preliminary action before the target is unexpectedly displaced (See Figure
2). This is particularly problematic because it has been shown that longer preparatory phases
for an action lead to greater challenges in later modifying or inhibiting that action (Lappin &
Eriksen, 1966; Logan, 1981). It is important to note that in contrast to target perturbations at
limb movement onset, target jumps elicited during a saccade would not alter the preparatory
phases between groups because PD patients and controls have similar pro-saccade onset
latencies and durations. Therefore, only in the experiment probing conscious online motor
control, where the target displacement was linked to limb movement onset, would the
preparatory phases have been increased for the PD patients relative to the healthy controls.

	
  

19	
  

	
  

Given this confound, the mechanism underlying impairments in online motor control for PD
patients observed by Desmurget in the double-step paradigm remains unclear.

Figure 2. Schematic of a Hypothetical Timeline for Target Displacement at Hand
Movement Onset for (1) healthy controls and (2) PD patients. The red line represents
the preparatory phase towards the initial target location.
	
  

1.3 The Current Study
1.3.1 Rationale for Current Study
In Desmurget et al. (2004), PD patients were impaired in altering their handmovement trajectories when target displacements occurred at hand-movement onset, but not
when target perturbations occurred during the saccade using the classic double-step
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paradigm. Traditionally, when target jumps occur at hand-movement onset, they are
consciously perceived, in contrast to when they occur during a saccade. Due to diseaseassociated bradykinesia, however, target jumps that occur at hand-movement onset also
produce longer action preparation phases toward the initial reach target in PD patients
compared to controls. Indeed movement onset latencies, and hence the preparation of the
movement trajectory that ultimately had to be revised, were on average 120 ms longer for PD
patients compared to controls. Consequently, the interpretation of Desmurget’s pattern of
results is confounded. These results could reflect impairments for PD patients for automatic
online movement adjustments when the need for this alteration is consciously perceived as
Desmurget has argued. Equally possible, however, this pattern of findings could have arisen
because PD patients had an increased preparatory phase for the initial target reach trajectory
relative to the preparatory phase of controls. It has been shown that longer preparatory phases
for actions leads to greater challenges in later modifying or inhibiting those actions (Lappin
& Eriksen, 1966; Logan, 1981). This introduced a significant, unintended disadvantage for
PD patients that alone could account for their deficient performance. The aim of the current
study was to directly contrast automatic online motor corrections that were unconscious
versus conscious, eliminating conditions that would disadvantage PD patients owing to their
motor symptoms.

1.3.2 Objective
The main objectives of the present study are two-fold. First, we aimed to develop a
double-step paradigm that directly dissociated perceptual awareness of a target displacement
from potential confounding effects of PD-related bradykinesia. Second, using our adapted
paradigm, we aimed to explicitly elucidate the effects of conscious-iterative control on
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automatic online motor adjustments in patients with PD and healthy controls. Taken together,
we aimed to systematically consider how PD-related bradykinesia might have confounded
the previous approaches used to investigate automatic online motor control with and without
conscious perception. Furthermore, this research aimed to provide insight into the role of the
basal ganglia in online motor control at the behavioral level.

1.3.3 Predictions
An alternative explanation for previously observed PD-related impairments in
conscious online corrections lies in the assumption that the preparatory phase timing affects
one’s ability to perform rapid online motor adjustments. In line with this, we predicted that
when confounding effects of bradykinesia are accounted for (i.e. the preparatory phase is
equalized between PD patients and healthy controls) that the two groups will perform
consciously-perceivable online corrections more similarly. We predicted that corrections
made in response to either consciously-perceived or subliminal target jumps will not
significantly differ for patients with PD and healthy controls.

Chapter 2: Methods
2.1 Participants
This study included 12 patients with clinically diagnosed idiopathic PD and 12
healthy age-matched controls. All participants provided written and informed consent
according to the Declaration of Helsinki (1991) and all procedures were approved by the
Health Sciences Research Ethics Board of the University of Western Ontario (London,
Ontario, Canada). Participants did not have previous experience with the task, were naïve to
the purpose of the experiment and were right-handed. Controls had no history of neurological
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illness, major psychiatric disorder, motor deficits or head trauma. Additionally, healthy
controls were not taking any cognitive-enhancing medications and had no history of
substance abuse. All participants had normal or corrected-to-normal vision. A complete list
of inclusion criteria is included in Appendix H. The age of PD patients (M = 64.83, SD =
9.41) and the age of controls (M = 65.0, SD = 8.62) did not significantly differ. In addition,
controls were matched to PD patients for education. A complete outline of population
demographics is included in Table 1.
Patients with PD were all levodopa responsive and were taking dopaminergic
medication at the time of testing. The daily levodopa equivalent dose (M = 673.2 mg, SD =
356.67) was calculated in accordance with Evans et al. (2004): levodopa dose + levodopa x
1/3 if on entacapone + bromocriptine (mg) x 10 + cabergoline or pramipexole (mg) x 67 +
ropinerole (mg) x 20 + pergolide (mg) x 100 + apomorphine (mg) x 8. PD patients did not
report any cognitive complaints and were all found to be cognitively unimpaired in
accordance with the standard MoCA examination (M = 27.33, SD = 1.37). Patients and
controls were excluded if they scored less than 25/30 on the MoCA. Furthermore, patients
had no history of any additional neurological illnesses unrelated to PD, had no suspicion of
familial forms of PD, had no history or current treatment with deep brain stimulation and
were not taking any cognitive-enhancing medications.
All patients participated in two identical testing sessions on separate days: once while
taking their usual dopaminergic therapy as prescribed by their treating neurologist, and once
following withdrawal from dopaminergic medication. In the Off dopamine session, patients
were instructed to abstain from taking all dopaminergic medications including dopamine
precursors such as levodopa, aromatic-L-amino-acid decarboxylase inhibitors such as
carbidopa, and catechol-O-methyltransferase (COMT) inhibitors such as entacapone for a
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minimum of 12 to a maximum of 18 h, and dopamine agonists, such as pramipexole
(Mirapex), ropinirole (Requip) or pergolide (Permax), as well as amantadine (Symmetrel),
rasagiline (Azilect), and selegiline (Eldepryl or Deprenyl) for 16–20 h prior to testing.
Similarly, all healthy controls participated in two distinct testing sessions, examining
the effects of dopamine medication (100 mg levodopa + 25 mg carbidopa, orally) versus
placebo (identical cornstarch placebo) on separate days. Healthy participants were thoroughly
screened using the Levodopa Safety Screening Questionnaire prior to their participation
(Appendix I). Administering levodopa to healthy controls allowed us to directly investigate
the effects of this medication independent from any PD pathology on online motor control.
All On-Off medication orders were counterbalanced across participants and the On-Off order
was identical for each PD patient and his/her age- and education-matched healthy control
participant.
The presence and severity of PD symptoms was assessed for each patient, both on and
off dopaminergic medication, using the Unified Parkinson’s Disease Rating Scale (UPDRS)
Motor Subscale. Control participants were also assessed using the UPDRS to screen for any
undiagnosed motor or neurological illnesses. All participants completed a series of
standardized cognitive and affective screening tests (Appendix C- G). The mean cognitive
and affective screening scores and the UPDRS motor subscale scores are included in Table 1.
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Table 1. Demographic, clinical information, and screening cognitive and affective
measures for participants with PD and controls
Group

Age

Edu

Duration

Levodopa
Dose

UPDRS

ANART BDI-II

BAI

Apathy

MOCA

64.83
(2.72)

15.67
(0.99)

6.58
(1.37)

673.21
(102.9)

—

—

10.67
(1.29)

8.92
(1.50)

10.92
(1.15)

—

On
(n=6)

62.00
(4.18)

15.17
(1.57)

7.00
(1.89)

632.00
(125.77)

9.20
(1.85)

126.09
(2.30)

9.17
(2.02)

6.50
(2.45)

9.00
(0.82)

27.50
(0.72)

Off
(n=6)

67.66
(3.43)

16.17
(1.30)

6.17
(2.15)

714.42
(173.63)

12.42
(2.03)

—

12.17
(1.51)

11.33
(2.39)

12.83
(1.92)

—

Control
(n=12)

65.00
(2.48)

15.92
(0.88)

—

—

—

—

2.75
(0.70)

2.75
(0.93)

9.17
(1.02)

—

On
(n=6)

65.66
(4.07)

16.83
(1.11)

—

—

0.167
(0.167)

—

3.83
(0.91)

2.17
(0.87)

7.83
(1.60)

—

Off
(n=6)

64.50
(3.28)

15.00
(1.36)

—

—

0.00

127.47
(2.08)

1.67
(0.92)

3.33
(1.71)

10.50
(1.15)

28.5
(0.43)

64.83
(2.72)

15.67
(0.99)

6.58
(1.37)

673.21
(102.9)

—

—

10.58
(1.59)

7.42
(1.29)

11.42
(1.67)

—

On
(n=6)

67.66
(3.43)

16.17
(1.30)

6.17
(2.15)

714.42
(173.63)

10.83
(2.21)

128.65
(1.29)

12.67
(2.72)

8.00
(2.31)

15.17
(2.18)

27.17
(0.40)

Off
(n=6)

62.00
(4.18)

15.17
(1.57)

7.00
(1.89)

632.00
(125.77)

12.0
(2.00)

—

8.50
(1.45)

6.83
(1.35)

7.67
(1.38)

—

Control
(n=12)

65.00
(2.48)

15.92
(0.88)

—

—

—

—

2.67
(0.49)

2.50
(1.09)

8.75
(1.12)

—

On
(n=6)

64.50
(3.28)

15.00
(1.36)

—

—

0.00

—

2.17
(0.65)

3.17
(2.01)

11.17
(1.05)

—

Off
(n=6)

65.66
(4.07)

16.83
(1.11)

—

—

0.00

126.42
(1.79)

3.17
(0.75)

1.83
(1.01)

6.33
(1.45)

27.833
(0.65)

Day 1
PD
(n=12)

Day 2
PD
(n=12)

Values are presented as group means (SEM). Screening cognitive and affective measures were
completed by participants with PD on medication and by healthy controls off medication. All control
participants presented with normal neurological exams. Session 1 refers to the first day of testing.
Session 2 refers to the second day of testing. Edu, years of education; Duration, years since diagnosis
of PD; Levodopa dose, equivalent dose in mg; UPDRS, Unified Parkinson's Disease Rating Scale;
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ANART, National Adult Reading Test IQ Estimation; BDI-II, Beck Depression Inventory II score;
BAI, Beck Anxiety Inventory I score; Apathy, Apathy Evaluation Scale score; MoCA, Montreal
Cognitive Assessment measured for participants with PD and for matched control participants.

2.2 General Design
A modified double-step, pointing paradigm was employed. The premise of the task
remained the same: participants were instructed to point to a peripheral visual target, which
depending on the trial, either remained stationary or unexpectedly changed locations. To
eliminate any confounding effects of bradykinesia, in one condition, we induced online,
automatic motor corrections that were consciously perceived in a way that was independent
of hand movement initiation compared to another condition in which these perturbations
were not consciously noted. To this end, we introduced two sizes of target perturbations:
small (3.5 cm) and large (7 cm), both of which occurred during the initial saccade. Given that
visually-guided saccades have not previously been shown to be delayed in PD (Armstrong et
al., 2002; Briand et al., 1999; Chan et al., 2005), introducing a target displacement during this
time would render the initial preparatory phase equivalent for PD patients and healthy
controls. Furthermore, by modifying the target jump size, we expected small perturbations to
fall below the threshold for conscious perceptual awareness, whereas the larger perturbations
would exceed the threshold for awareness (Goodale et al., 1986; Pélisson et al., 1986). To
confirm that this method was effective, participants began and ended each session with a
two-alternative forced choice task in which we directly assessed their conscious perceptual
awareness of the target displacements.

2.3 Apparatus and Stimuli
Participants sat at a table in a darkened room with their head stabilized in a chin-rest.
A pressure-sensitive start button was fastened to the table directly in front of the participant
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and approximately 10 cm from the edge of the tabletop. The stimuli were presented on a
vertically mounted custom-built display board. The board consisted of a horizontal array of
red light emitting diodes (LEDs) set below a transparent Plexiglas surface. Each LED was 5
mm in diameter. The board was secured to the table such that the leftmost LED, which
functioned as the fixation point, was positioned at the midline 40 cm in front of the subject
and aligned with the start button. All other LEDs served as targets and were horizontally
aligned at 7 distances to the right of the fixation point: 24.5, 28, 31.5, 35, 38.5, 42, 45.5 cm
(See Figure 3). These targets are referred to as T1-T7 respectfully.
Infrared-light emitting diodes (IREDs) were attached to the participant’s right index
finger and inner wrist with adhesive tape. The experimenter ensured that the pad of the
participant’s index finger was unobstructed. The diode wires were secured to permit
unrestricted arm movements. The 3D positions of the IREDs were recorded with an
optoelectronic motion capture system, Optotrak Certus (Northern Digital, Waterloo, ON,
Canada) at 200 HZ. Monocular eye position was recorded at 1000 HZ with the Eyelink 1000
table-mount eye-tracking system (SR Research, Mississauga, ON, Canada). The camera lens
was positioned approximately 60 cm from the participant’s head. The eye tracker was
calibrated for every participant, and drift correction was routinely performed according to the
manufacturer’s guidelines and standards. The synchronization between Optotrak and Eyelink
recordings and the stimuli display board was achieved using custom-designed software.
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Figure 3. Schematic of Experimental Setup. The fixation point (FP) and the target
lights are represented by red circles. Only one red light was illuminated at a time during
the actual experimental procedure. The participant began each trial with their right
pointer finger depressed on the start button (SB).
	
  

2.4 Procedure
Experimental procedures were identical in both Session 1 and Session 2. All
participants performed a target displacement judgment task and a pointing task in a darkened
room. For both the perceptual judgment and pointing tasks, participants began by staring at a
central fixation point. As soon as the fixation point was extinguished, an LED light became
illuminated at one of seven peripheral locations (T1-T7) to act as the target. Participants were
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instructed to look towards the target as quickly and as accurately as possible. The target
would either remain stationary or would be unexpectedly displaced by a distance of 3.5 cm or
7 cm during the participant’s initial orienting saccade. Specifically, on jump trials, target
displacements were elicited once the saccade reached a velocity threshold of 50 deg/s. Target
displacements were only initiated from either T3 or T5 locations and could occur either to the
left or to the right of the original target location (See Figure 4). The distance between each
target was 3.5 cm, meaning that a small displacement would constitute a jump from T3 to T2,
T3 to T4, T5 to T4, or T5 to T6, whereas a large displacement would include those directed
from T3 to T1, T3 to T5, T5 to T3, and T5 to T7. Each target jump type specified by size,
direction, and starting position, occurred with equal frequency throughout the experiment. A
detailed description of each condition type is listed in Table 2. For all statistical comparisons,
analyses of variance (ANOVAs) were considered significant when the p-value, corrected for
multiple comparisons, was < .05. The specifics of the target displacement judgment task and
pointing task differed as follows.
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FP

First Step

T3

T4

Second Step

Figure 4. Schematic of Visual Display for an Example Double-Step Trial. The
participant begins by staring at the central fixation point. A target will appear in the
periphery (T3 shown here) and will either remain stationary (single-step condition) or
will be displaced to the left or to the right, a small or a large distance (double-step
condition: T3T4 shown here).
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Table 2. Detailed description of each condition type
Trial
Label

Type

Initial
Target
Position

Final Target
Position

Distance From Fixation
Point to Final Target
Position (cm)

Size

Direction

T1

Stationary

1

1

24.5

----

----

T2

Stationary

2

2

28

----

----

T3

Stationary

3

3

31.5

----

----

T4

Stationary

4

4

35

----

----

T5

Stationary

5

5

38.5

----

----

T6

Stationary

6

6

42

----

----

T7

Stationary

7

7

45.5

----

----

T3T1

Jump

3

1

24.5

Large

Left

T3T2

Jump

3

2

28

Small

Left

T3T4

Jump

3

4

35

Small

Right

T3T5

Jump

3

5

38.5

Large

Right

T5T3

Jump

5

3

31.5

Large

Left

T5T4

Jump

5

4

35

Small

Left

T5T6

Jump

5

6

42

Small

Right

T5T7

Jump

5

7

45.5

Large

Right

Targets could either remain stationary or could unexpectedly change location during the initial
orienting saccade. Initial target position refers to the location of the first LED light illuminated within
a trial. Final target position denotes the location of reach endpoint. Large target jumps were 7 cm in
size and small target jumps were 3.5 cm. Direction refers to the laterality of the target jump relative to
its initial position.
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2.4.1 Target Displacement Judgment Task
Each block of the target displacement judgment task consisted of 16 ‘pairs’ of trials.
A ‘pair’ of trials was defined as the sequential presentation of a jump and a stationary trial.
Each trial type was presented 2 times, for a total of 4 trials per type. The pairing of stationary
and jump trials was randomized and the order of presentation was counterbalanced.
Following each pair of trials, participants were instructed to verbally report if they thought
the target had jumped in either “Trial A” or “Trial B”. The percentage of correct responses
were calculated and compared to chance level.

2.4.2 Double-Step Pointing Task
Participants began each trial by depressing a pressure sensitive start button with their
right index finger and staring at the fixation point for 500-1500ms. Their left hand rested in
their lap. Upon appearance of the peripheral target, participants were instructed to release the
start button and point to the final target as quickly and as accurately as possible. The task
consisted of 222 trials. To prevent any predictive behavior, the target remained static in 57%
of the trials and was displaced in 43% of the trials. Therefore, each stationary condition was
presented 18 times, whereas each jump condition was presented 12 times. Jump and
stationary trials were randomly interspersed and the trial order was randomized across
participants. The target remained visible for the duration of the movement and extinguished
when the participant touched it with their pointer finger. Upon touching the target,
participants were instructed to return their right pointer finger to the start button to initiate the
next trial (See Figure 5).
Prior to experimental trials, participants performed a practice block until they became
comfortable with the task
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(500-1500ms)

Fixation point off
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Saccade and limb motor plan
initiated towards target
Time
Target is displaced 3.5 or 7 cm
to the left or to the right of the
initial target location
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Limb movement
onset
T2

Finish pointing to target

Return to start
button

Figure 5. Timeline of Trial Events. Schematic representation of trial events across
time in the double-step pointing task. Adapted from Johnson & Haggard (2005).
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2.5 Data Processing and Analyses
2.5.1 Target Displacement Judgment Task
To assess perceptual awareness of the target jump, the percentages of correct
responses for each group and for each jump size were compared to the chance level 50%
using separate one-sample t-tests. Further, we ran a 2 × 2 × 2 mixed ANOVA with Group as
the between-subject factor (PD vs. Control) and Dopamine Medication Status (On vs. Off)
and Target Jump Size (Large vs. Small) as the within-subject factors. The dependent variable
was percentage of correct responses.

2.5.2 Double-Step Pointing
Analyses were performed in two steps. First, we analyzed eye and hand movements
directed towards stationary targets. Second, we evaluated the effect of target displacement on
reach kinematics and trajectories. For both steps, the kinematics of each trial were analyzed
offline. To isolate the dependent variables, we restricted the data set to include only points
during which the hand was in motion in the forward reach trajectory. Thus, we defined the
beginning of the movement as the first of 5 consecutive sample frames in which the wrist
IRED exceeded a threshold velocity of 40 mm/s. We defined the end of the movement as the
frame with the maximum y-spatial coordinate. If a straight line was drawn between the start
button and the array of target lights it would represent increasing depth distance (y-axis).
Therefore, the maximum y-spatial coordinate corresponded to the end position when the full
reach distance was achieved (i.e. when target was touched).
The specifics of each analysis are described below.
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Eye Movements: Stationary Targets
The variable of interest extracted from the eye tracking data was saccade RT. The
validity of the experiment was predicated on the premise that saccade RT, and thus timing of
target perturbation, did not vary across groups. To confirm this, we ran a 2 × 2 repeated
measures ANOVA with Group as the between-subjects factor (PD vs. Control) and
Dopamine Medication Status (On vs. Off) as the within-subject factor.
The saccade of interest was determined as the first saccade greater than 2 degrees that
occurred after the initial target light became illuminated.

Kinematic and Reach Trajectories: Stationary Trials
The following dependent variables were extracted from the kinematic data to evaluate
performance on stationary trials: hand RT, MD, maximum acceleration, and peak velocity.
Hand RT was defined as the time it took to release the start button and to initiate the pointing
movement following the illumination of a peripheral target. MD referred to the time from
movement onset to reaching the target and therefore movement offset.
Separate 2 (Group: PD vs. Control) × 2 (Dopamine Medication Status: On vs. Off)
mixed ANOVAs, with Group as the between-subject factor and Dopamine Medication Status
as the within-subject variable were performed on the four dependent measures.

Kinematic and Reach Trajectories: Jump Trials
The principal dependent measures extracted to assess online corrections were MD
difference scores and point of divergence. MD difference scores were calculated with the
following equation: Mean MD Jump Target (A) – Mean MD Stationary Target (B) à Target
(A). This value was calculated individually for each participant and for each jump condition.
This concept can best be illustrated with an example. To determine the MD difference score
	
  

35	
  

	
  

for when a target first appeared at Position 3 and was subsequently displaced to Position 1
(i.e. T3T1), the mean MD for the stationary T1 condition would be subtracted from the mean
MD for the jump T3T1 condition.
A 2 x 2 x 2 mixed ANOVA was performed with the between-subjects factor as Group
(PD vs. Control) and the within-subject variables as Dopamine Medication Status (On vs.
Off) and Target Jump Size (Small vs. Large). We also computed an additional repeated
measures ANOVA including the within-subject factor Direction (Left vs. Right) to confirm
that laterality did not have an effect on the dependent variable.
Point of divergence was characterized as the frame at which a reach trajectory on
jump trials diverged away from its original hand path to reach the new target location. To
determine this point, reach trajectories were first smoothed and normalized in accordance to
functional data analysis techniques established by Ramsay and Silverman (2002). In brief, for
each participant, on each trial, trajectories were fitted with 6-order b-splines to the x, y, and z
spatial coordinates. The data were normalized such that each trajectory was defined at 300
points equally spaced in the y-dimension. As such, the continuously defined data curve
constituted a single functional observation, rather than its individual discrete data points
(Ramsay & Silverman, 2002; Levitin et al., 2007). We conducted a set of planned mixed
functional ANOVAs to contrast each jump type with its corresponding stationary condition
(either T3 or T5), across Dopaminergic Medication Status (within-subject: On vs. Off) and
Group (between-subject: PD vs. Control). Functional ANOVAs were performed in Matlab
2014 using customized code adapted from http://www.psych.mcgill.ca/misc/fda/. Functional
ANOVAs extend the uni-variate ANOVA to all points in a trajectory. In this manner, a single
functional comparison is performed through the implementation of individual repeated
measures ANOVAs at each frame. Critically, these multiple comparisons do not violate
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statistical sense as these multiple analyses are only run as a ‘surrogate’ for a single statistical
comparison of the entire function (Ramsay & Silverman, 2002). We defined the point of
divergence as the point at which greater than 10 consecutive time points for jump trial
conditions differed significantly from their respective stationary trial condition at p < 0.05,
corrected for multiple comparisons.

Chapter 3: Results
First, we empirically evaluated the effects of small (i.e., 3.5cm) and large (i.e., 7cm)
intra-saccadic target jumps on conscious perceptual awareness. Second, to isolate any
baseline differences between the PD and the control group, we examined ocular and limb
kinematics directed towards stationary peripheral targets. Lastly, we assessed online motor
performance in response to large, consciously-perceived, and small, subliminal target
displacements.

3.1 Target Displacement Judgment Task: Perceptual
Awareness Results
Target jump size had a significant effect on the percentage of correct responses [F (1,
22) = 221, MSe = 228, p < .001], with greater accuracy resulting for large relative to small
target jumps. This confirmed that the size of the intra-saccadic target jump influenced
conscious perceptual awareness (Figure 6). The main effects of Group and Dopaminergic
Medication Status, and the Group x Target Jump Size, Group x Dopaminergic Medication
Status, Dopaminergic Medication Status x Target Jump Size, and Group x Target Jump Size
x Dopaminergic Medication Status interactions were not statistically significant, all F < 1.
Overall, participants correctly identified 82.4% of the large intra-saccadic target
jumps and only 50% of the small intra-saccadic target jumps. One-sample t-tests indicated
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that accuracy rates for both groups were significantly greater than the 50% chance level for
large intra-saccadic target jumps [t(11) = 13.827 p < .001 for PD; t(11) = 16.679, p < .001 for
controls]. In contrast, accuracy rates for both groups did not significantly differ from 50%
chance level for small intra-saccadic target jumps [t(11) = -0.089, p = 0.534 for PD; t(11) =
0.104, p = 0.919 for controls].

***
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Percent Correct Response

80
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Control

40
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20
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Target Jump Size

Figure 6. Percentage of Correct Responses in Target Jump Judgment TwoAlternative Forced Choice Task. Correct responses are shown as a function of
target jump size. Means of the percentage of correct responses are collapsed across
medication status for both groups (nPD=12; ncontrol =12). The error bars reflect
standard error about the mean.
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3.2 Saccade RT and Target Jump Timing Results
A 2 x 2 mixed ANOVA revealed no main effect of Group [F(1,22) = 2.015, MSe =
2767, p = 0.170] or Dopaminergic Medication Status [F(1,22) = 1.497, MSe = 71.84 p =
0.234] on saccade RT. The interaction between Medication Status and Group was significant
[F(1,22) = 8.999, MSe = 71.84 , p <.05, Figure 7] reflecting a slight decrease in saccade RT
for controls and a slight increase in saccade RT for PD patients while on dopaminergic
medication. To follow up, we directly confirmed that the exact timing of the target jump did
not significantly differ between Groups [F(1,22) = 0.158, MSe = 1162, p = 0.695] or across
Medication Status [F(1,22) = 1.96, MSe = 137.9, p = 0.180]. Further, these variables did not
interact [F(1,22) = 1.404, MSe = 137.9, p = 0.249]. This confirmed that equal preparatory
phases occurred for both groups and across all conditions.
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Figure 7. Primary Saccade Reaction Time (RT) in Response to Initial Target
Appearance. RT is presented as a function of dopaminergic medication status for PD
participants (n=12) and matched controls (n=12). The mean values are presented with the
error bars reflecting standard error about the mean.
	
  

3.3 Limb Movement Characteristics: Stationary Trials
Patients with PD exhibited significantly longer hand RTs [F(1,22) = 4.327, MSe =
3.15 x 104, p <.05, Figure 8] and significantly decreased peak velocities compared to healthy
controls [F(1,22) = 4.449, MSe = 2.38 x 105, p <.05]. However, there was no significant main
effect of group on overall MD [F(1,22) = 2.331, MSe = 2.37 x 105, p = 0.141], nor on
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maximum acceleration [F1,22 = 2.374, MSe = 5.18 X 107, p = 0.138]. Medication status did
not significantly affect any of the dependent variables including hand RT, MD, peak velocity,
and maximum acceleration, all F < 1. Similarly, Medication Status did not significantly
interact with Group for any of these dependent variables [F(1,22) = 0.580, MSe = 2419, p =
0.455 for hand RT; F(1,22) = 0.054, MSe = 5.01 x 104, p = 0.819 for MD; F(1,22) = 0.234,
MSe = 1.55 x 104, p = 0.633 for peak velocity; F(1,22) = 0.461, MSe = 1.39 x 107 , p = 0.504
for maximum acceleration]. 	
  

3.4 Limb Movement Characteristics: Jump Trials
A defining trait of automatic online corrections is that they do not increase the overall
MD. Our results revealed that patients with PD abide by this trend, both when the online
corrections were consciously perceived and when they were subliminal. Separate t-tests
indicated that MD difference scores for jump trials minus stationary trials were not
significantly different from zero for the PD group across any of the condition types [t(11) =
1.393, p = 0.191 for PD Off Large; t(11) = -1.047, p = 0.318 for PD Off Small; t(11) =
0.409, p = 0.690 for PD On Large; t(11) = 1.383, p = 0.194 for PD On Small, Figure 9A].
Similar findings were observed in controls, with two notable exceptions. Controls
demonstrated MD difference scores significantly greater than zero for large target jumps
while off of dopamine medication [t(11) = 3.071, p < .05)] and for small target jumps while
on dopamine medication [t(11) = 3.329, p < .01)]. MD Difference scores were not
significantly different from zero for the control group for any of the other conditions [t(11) =
1.687, p = 0.120) for Controls Off Small; t(11) = 1.749, p =0.108) for Controls On Large,
Figure 9B].
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Critically, the mixed ANOVA revealed that MD difference scores were not
significantly different between Groups [F(1,22) = 2.179, MSe = 950, p = 0.154], across
Dopaminergic Medication Status [F(1,22) = 0.314, MSe = 829.81, p = 0.581] or Target Jump
Size [F(1,22) = 0.513, MSe = 2193, p = 0.48]. PD patients and healthy age-matched controls
exhibited equivalent changes in MD, regardless of conscious versus unconscious perception
of target jumps or medication status. A significant interaction was only demonstrated
between Dopaminergic Medication Status and Target Jump Size [F(1,22) = 4.594, MSe
=1045 , p <.05], such that participants overall, collapsing across groups, exhibited increased
MD difference scores for small/subliminal target displacements on relative to off
dopaminergic medication with no effect on larger target jumps.
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Figure 8. Primary Hand Reaction Time (RT) in Response to Initial Target
Appearance. RT is presented as a function of dopaminergic medication status for PD
participants (n=12) and matched controls (n=12). The mean values are presented with
the error bars reflecting standard error about the mean.
	
  

	
  

43	
  

	
  

MD Difference (ms)

A)

60	
  

60	
  

60	
  

60	
  

40	
  

40	
  

40	
  

40	
  

20	
  

20	
  

20	
  

20	
  

0	
  

0	
  

0	
  

0	
  

-‐20	
  

-‐20	
  

-‐20	
  

-‐20	
  

-‐40	
  

-‐40	
  

-‐40	
  

-‐40	
  

-‐60	
  

Off_Large

-‐60	
  

On_Large

-‐60	
  

60	
  

60	
  

40	
  

40	
  

40	
  

20	
  

20	
  

20	
  

20	
  

0	
  

0	
  

0	
  

0	
  

-‐20	
  

-‐20	
  

-‐20	
  

-‐20	
  

-‐40	
  

-‐40	
  

-‐40	
  

-‐40	
  

-‐60	
  

On_Large -‐60	
  

40	
  

MD Difference (ms)

Off_Small

60	
  

60	
  

B)

-‐60	
  

-‐60	
  

*	
  

Off_Large

-‐60	
  

Off_Small

On_Small

*	
  

On_Small

Figure 9. Movement Duration (MD) Difference Scores Compared to Zero. (A) PD
patients (n=12) (B) Controls (n=12). MD differences are displayed for each medication
status and target jump size. Participants performed the task in either the On-Off or OffOn medication orders. The error bars reflect a 95% confidence interval.
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As illustrated in Figures 10 and 11, target end-position had a significant effect on
lateral deviation throughout the reach for both healthy controls and PD patients, regardless of
medication status. When the target jumped from its original position to the left, a noticeable
leftward shift in reach direction occurred relative to the magnitude of the displacement.
Similar patterns in online reach adjustments were observed for rightward target
displacements. To further investigate this effect, we implemented individual 2 x 2 x 2 mixed
measures functional ANOVAs to assess pair-wise comparisons between jump trials and their
relative stay trials across the movement trajectories. Group was the between-subject factor
(PD vs. Control) whereas Target Condition (Jump vs. Stay) and Dopaminergic Medication
Status (On vs. Off) were within-subject variables. A functional main effect of Target
Condition (i.e. Jump vs. Stay) revealed the percentage of the trajectory travelled before the
two trajectories significantly differed from one another. Furthermore, we examined
interactions between Group, Medication Status and Target Condition to investigate whether
these factors and variables jointly or differentially impacted reach divergence. There were no
significant effects of Group or Dopaminergic Medication Status on divergence scores.
Half of our jump trials were initiated from T3 and half were initiated from T5. We
report our divergence analyses relative to this preliminary target position, as divergence was
based upon relative deviations from the original target trajectory path. For trajectories
initially directed to T3, large target displacements had a relatively early effect on reach
trajectories, such that a smooth divergence was noted at 16% and 26% into the total ymovement for T3T1 and T3T5 trials respectively. This divergence from stay trials was
maintained for the remainder of the pointing trajectory such that the difference between stay
and jump trials was noted for 84% and 74% of the movement for T3T1 and T3T5 trials
respectively. Similar results were observed for large displacements for movements initially
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directed at T5. T5T3 diverged at 25% and T5T7 diverged at 14% into the total y-movement
with differences in trajectory being significant between stay and jump trials for 75% and 86%
of the pointing movement respectively. The pair-wise functional comparisons of small target
displacements revealed a smooth divergence in reach trajectories at 31%, 30%, 28% and 42%
of the total y-movement for T3T2, T3T4, T5T4 and T5T6 conditions respectively. All jump
trajectories significantly differed in the x-dimension from their relative stay trial from the
identified point of divergence onwards (i.e. until the endpoint of movement). That is, the
small target displacements stay and jump trajectories were significantly different for 69%,
70%, 72%, and 58% of the movement for T3T2, T3T4, T3T5 and T5T6 conditions
respectively. A significant interaction between condition and group was observed only for
T3T4 trials between frames 20 (at 6% of total y-movement) and 46 (at 15% of total ymovement) for a duration of 9% of the trajectory. Group did not interact with condition in
any of the other functional pair-wise comparisons, suggesting that disease status did not
significantly affect the ability to diverge trajectories online. Similarly, Medication Status
significantly interacted with Condition for only the T5T4 pairwise-comparisons between
frames 9 (at 3% of total y-movement) and 26 (at 9% of total y-movement), for a duration of
6% of the trajectory. All other functional comparisons did not reveal any significant
interactions between Group or Medication Status. This indicates that PD diagnosis and
medication status did not significantly influence the point at which movements began to
diverge when target location moved relative to when the target position remained invariant.
Of importance, there was not a significant 3-way interaction between Group, Medication
Status, and Condition (i.e., stay vs. jump) for any of the functional pair-wise comparisons.
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Chapter 4: Discussion
4.1 General Summary of Results
In the present study, we investigated the extent to which in-flight reach corrections
could be performed automatically in a sample of PD patients, both with and without
conscious awareness of the need for reach adjustments. The validity of our methodological
design relied on the premise that saccade RT, and thus the target jump timing, did not differ
between groups or across medication status. We directly confirmed that orienting saccades
were not delayed in PD, and further that medication status did not alter saccade latency. As a
control, we directly confirmed that the latency of the target jump was in fact equal between
groups and across medication statuses. An alternative forced-choice task was used to
empirically confirm that altering the size of intra-saccadic target jumps was an effective
method for manipulating conscious perceptual awareness. More specifically, small intrasaccadic target jumps were presented below the threshold for conscious perceptual awareness
of change, whereas large intra-saccadic target jumps reached threshold for conscious
perceptual awareness. Dopaminergic medication did not significantly affect either group’s
perceptual threshold. Taken together, we were able to manipulate conscious awareness of
target jumps independent of motor demands, rendering all conditions more equivalent in
terms of difficulty for PD patients and healthy controls.
To assess baseline differences in hand kinematics, we first assessed performance
during stationary target trials. An overall increase in hand RT and decrease in peak velocity
was observed for PD patients relative to controls, indicating that the patient group
experienced disease-associated bradykinesia. In accordance with our original critique, our
results support the notion that triggering a target displacement at hand movement onset, as
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per previously applied methodology, would increase the initial preparatory phase for the PD
group relative to the healthy controls. Critically, no other movement characteristics differed
between groups, allowing for more straightforward assessment of the online motor corrective
system in perturbed target trials.
MD difference scores were equivalent between our control and patient groups for all
sized target jumps and across all medication statuses. In our PD group, target displacements
did not affect the overall MD for both consciously perceived and subliminal online
corrections. This is analogous to the pattern observed in healthy young controls. These results
stress the similarity in performance of consciously perceived versus subliminal online motor
corrections in PD patients. This pattern implies that the degree of consciousness and control
over the corrective system is irrelevant for the engagement of the automatic pilot in PD
participants.
For our healthy, elderly controls, we did find that in two out of four conditions, MD
difference scores were greater than zero (i.e., jump target trajectories took significantly
longer than stationary target trials). Despite this increase in MD, smooth, online corrections
still occurred early into the movement execution for healthy age-matched controls. Again,
these corrections were statistically equal to those of PD patients and were unaffected by
dopaminergic therapy.
The most significant findings of this study relate to the intact automatic processing of
the corrective system in PD. After controlling for potential confounds, we showed that
conscious awareness did not affect the online reach corrections of PD patients. Specifically,
we did not find any differences in terms of where trajectories diverged for jump trials relative
to stationary trials between PD and control groups for either small, undetected, or large, and
hence consciously-perceived, target jumps. Moreover, our kinematic analysis included eight
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replications in each of the On and the Off dopamine medication sessions due to numerous
different endpoints and initial starting positions. For seven replications, the point of
divergence was not affected by dopaminergic medication and for seven replications, it was
not affected by group. These results were irrespective of jump size. There was one instance in
which Group and one instance in which Dopaminergic Status affected jump trajectory for
brief and unsustained periods during the movement trajectories. These differences were
observed for PD patients compared to controls during 6-15% of the trajectory period for
T3T4 and for dopaminergic therapy during the 3-9% of the trajectory for T3T5. These
differences in trajectories occurred before the point of sustained divergence between Jump
and Stay trials and their significance is unclear.

4.2 Online Motor Control in Healthy Ageing and in Parkinson’s
Disease
As mentioned in the General Summary of Results, target displacements were shown
to elicit increased MDs for healthy aged-matched controls in two out of four of our jump
conditions. Several previous studies have provided evidence for age-induced deficits in
online motor control, with older adults taking markedly longer to initiate corrections
(Plotnick et al., 1996; Rossit & Harvey, 2008; Sarlegna, 2006). Though delayed corrective
mechanisms in older adults might relate closely to general impairments in central planning
that naturally accompany ageing, Rossit and Harvery (2008) found that overall smoothness
and accuracy for older healthy adults for amended trajectories remained comparable to that of
younger adults, as we found here. In their study, Rossit and Harvery (2008) reported MD
difference scores of approximately 50 ms longer for elderly participants relative to younger
participants, leading them to suggest that the corrections of older adults remained too rapid
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for a new motor command to have been completely reprogrammed. Moreover, their data
showed that slowness in RTs was not restricted to perturbed double-step trials, but rather
older adults also took longer to initiate movements in unperturbed trials. Consequently, it was
argued that online corrections were still being performed with a high degree of automaticity;
however, general age-related declines in processing speed may have enhanced latencies in
their corrective movements. It is unclear whether this trend will persist in our data when an
increased number of participants are added.
Interestingly, in contrast, increases in MD were not observed for our PD group in any
of the jump conditions. Nonetheless, our data for PD participants appears to be trending in a
similar direction as the control results. One possibility for this anomaly between PD patients
and controls could relate to the greater within-group variability for our PD data that prevents
such trends from reaching significance. Provided that there is high heterogeneity in the
phenotypes of PD patients, it might be necessary to increase our power to observe significant
differences in MD for jump target trials relative to stay target trials (Foltynie et al., 2002;
Lewis et al., 2005). Though less likely, it might be possible that patients with PD are
refractory to age-related impairments in online motor control, owing to dorsal striatal
dysfunction enhancing automatic behavioural responses and online guidance (Benke et al.,
2003; Cameron et al., 2010; Cools et al., 2010; Klockgether et al., 1994; Reed, 1998). In
theory, dorsal striatal impairments might lead to motor performance being guided by greater
automaticity, yielding enhanced performance by PD patients on tasks such as the automatic
double-step paradigm. Alternatively, Reed (1998) posited that patients with PD might
experience increased reliance on online motor control as a compensatory mechanism for the
initial noise in their motor system during the pre-programming motor phase. Noise and
variability in the PD motor system might be attributable to dysregulation of striatal circuits,
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and thus inconsistent premotor cortex activation. Though speculative, our current data seems
to support the contention that striatal dysfunction might elicit an advanced online monitoring
and corrective system in PD to overcome these disruptions. The addition of more participants
will help clarify these hypotheses.
The greatest insight into the online corrective system comes from our analyses of the
reach divergence points. This functional analysis of online corrections indicated that neither
Group nor Medication Status interacted with Condition (i.e. divergence point) across any of
the frames for the vast majority of reach comparisons. The consistency in divergence scores
suggests that PD patients and healthy controls were able to elicit corrections at approximately
the same point in their reach trajectories and that these smooth changes in trajectory were
maintained once they occurred, irrespective of Group or Medication Status. However, Group
did interact with Condition for T3T4 comparisons between 6% and 15% of the overall
movements. We do not believe that this interaction is reflective of significant differences in
online corrections between groups. First, this interaction occurred at a non-critical point in
the overall reach trajectory. More importantly, there were no significant interactions at
relevantly defined points in the trajectory, such as at the point of divergence, which occurred
at 42% of the overall reach, or at reach endpoint. Similarly, Dopaminergic Status briefly
interacted with Condition at the 3-9% time points in overall movement trajectory for
displacements T5T4. Again, this point of interaction occurred well before the point of
divergence and reach endpoint. Increased path variability between-subjects may have led to
these two potentially spurious interactions earlier on in the reach. Further subjects should be
tested to investigate the significance of this finding.
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4.3 Conscious Awareness of Online Corrections
The main objective of this study was to elucidate how conscious perceptual
awareness of target position change affects PD patients’ ability to elicit automatic, online
reach corrections. Our results indicate that conscious awareness did not alter the degree to
which participants with PD could perform corrections automatically. Corrections in fact
started earlier for both PD and controls for the consciously-perceived target perturbations
relative to the subliminal perturbations. This was demonstrated by earlier correction times.
We attribute this difference to the size of the target displacement that had to be
accommodated with a smooth online change. We interpret that divergence appeared earlier
for larger (consciously-perceived) jumps because the change in direction is greater relative to
the small (subliminal) jumps. The corrective system will aim to make the change smooth and
gradual, even after the intention to change end point has been registered. It is therefore likely
that both sized jumps start to diverge at the same time, but this smaller change in trajectory
takes slightly more time to diverge significantly from the original trajectory, given more
similar endpoints for small relative to large jumps.
The results of the present study directly oppose those established by Desmurget et al.
(2004), which found PD-related deficits in consciously-perceived target changes, whereas
subliminal changes in target locations were performed normally by PD patients. We have
identified two potential explanations for our conflicting results. First, Desmurget et al. (2004)
applied a between-subject design, using different PD participants in their conscious doublestep task than in their subliminal double-step task, making their results less comparable
across these different experiments. Further, they included patients in both of their
experiments, one in which target changes were consciously perceived (n=5) and one in which
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they were not (n=7), who had atypical ages of PD onset (i.e., < age 40) and with highly
variable disease durations. These participant characteristics, as well as the small number of
patients, make their results less generalizable and reliable. PD is a highly heterogeneous
neurological disorder, often presenting differently among patients. For this reason, we used a
within-subject design to help limit any additional sources of variability within our data.
Furthermore, we applied strict inclusion and exclusion criteria, restricting our sample of PD
participants to ensure all patients had a specific diagnosis of idiopathic PD and presented
with typical PD features.
More significantly, as we discussed previously, Desmurget and colleagues (2004)
failed to dissociate the conscious perception of the target jump from the temporal aspects of
the target jump. Critically, in their study, consciously perceivable target displacements were
yoked to the initiation of a participant’s pointing movement, whereas subliminal target
displacements were yoked to initial pro-saccades. PD-related limb bradykinesia would have
led to target perturbation at movement onset, increasing the time PD patients had to plan and
prepare their action toward the initial target position. When we equalized the preparatory
phase between both groups, we did not find impairments in automatic action control, even
with consciously-perceived target displacement in our PD sample. Therefore, our data
suggest that the length of time one has to plan and prepare the initial action might influence
the overall motor fluidity and flexibility. A similar conclusion can be derived from previous
work that has collectively established temporal limitations on online corrections. For
example, Liu and Todorov (2007) demonstrated that young healthy adults were unable to
fully amend their trajectories in response to late-occurring target perturbations (i.e. 300 ms
following movement onset). Likewise, delayed corrections have also been observed when
targets are displaced at the time of peak movement velocity (Komilis et al., 1993). As a
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movement plan significantly progresses, the visuomotor system might become less efficient
at correcting potential errors (Liu & Todorov, 2007; Sarlegna & Mutha, 2014). One theory is
that the information surrounding the precise target location might become less relevant in the
latter parts of the movement as the motor control system is more heavily focused on endpoint
stability (Liu & Todorov, 2007). Undoubtedly, the visuomotor system must take into
consideration the costs (i.e. time and stability) and benefits (i.e. precision) before facilitating
an online correction. Taken together, we believe that the previously reported PD-related
deficits in conscious online motor control might have arisen as a consequence of additional
temporal constraints disproportionately affecting the PD group relative to the controls.

4.4 Role of Striatum/Basal Ganglia in Movement Generation
and Online Motor Control
Interestingly, we did not find a clear and significant effect of exogenous dopamine on
our measured motor variables. However, PD patients had significantly slower hand
movement RTs and peak velocities overall. We confirmed that PD participants properly
adhered to the medication schedule by performing clinical exams and estimating motor
function with the standardized UPDRS during both sessions. UPDRS scores were
significantly higher when participants were scheduled to be off of their dopaminergic
medication compared to when they were scheduled to be on their dopaminergic medication.
This also helped verify that testing did not occur during a “wearing-off” period for the On
testing sessions, when patients were taking their usual dopaminergic therapy.
It is worth noting that impairments in PD and correspondingly the magnitude of
improvements related to exogenous dopamine seem greater with increasing task complexity
(Benecke et al., 1987; Hanna-Pladdy & Heilman, 2010). That is, PD patients are expected to
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experience the greatest improvement in functioning with medication during more demanding
motor processes, such as when an action has to be initiated and a competing response is
inhibited or when complex motor sequences, with multiple, chained action plans are
performed (Hood et al., 2007; Shook et al., 2005). It is possible that the relatively simplistic
reaching movement that is elicited by a target is less impaired in PD and hence less sensitive
to On-Off differences. This interpretation is supported by reports that performance of PD
patients in simple behavioral paradigms, such as RT tasks, does not improve under
dopaminergic medication (Jahanshahi et al., 1992; Jordan et al., 1992; Müller et al., 2001).
Given that online motor corrections involve the smooth modulation of ongoing
responses and do not require complex motor switching, it is not completely unexpected that
PD participants performed this automatic function normally compared to age-matched
controls and that dopaminergic therapy did not alter performance. Further, the fact that we
did not find any between group differences in online corrections questions the role of the
dopaminergic system-striatum/basal ganglia in enactment of online motor corrections. In
theory, if dopaminergic pathways in the basal ganglia truly mediate the online corrective
response, then diminished dopamine supplies associated with PD would hinder functioning in
this domain. Similarly, replenishing these dopamine levels should improve performance.
In the literature there are conflicting reports as to the exact role, if any, of the basal
ganglia in the online control of action. Reduced capabilities in performing smooth and
efficient corrective movements online have been reported in only few experiments
investigating patients with HD (Smith et al., 1999) and PD (Desmurget et al., 2004; Tunik et
al., 2004). Although some groups have supported these clinical findings by showing
increased activity in the Gpi and STN of healthy controls during the error correction (Grafton
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& Tunik, 2011; Tunik et al., 2009), other groups have not (Desmurget et al., 2001;
Diedrichsen et al., 2005; Jueptner & Weiller, 1998).
Initially, our data appears to be at odds with previous clinical reports. However, we
suggest that evidence from HD patients must be interpreted cautiously. Given that atrophy
beyond the basal ganglia circuits is common even in the preliminary stages of HD, it is
difficult to attribute impairments in online movement guidance strictly to this region
(Ciarmiello et al., 2006; Hedreen et al., 1991; Rosas et al., 2008; Walker, 2007). Moreover,
in the few other studies reporting a role of the basal ganglia, corrective errors were evoked
through viscous mechanical perturbations of the limb or body position, which elicited the
additional need for dynamic control of force (Grafton & Tunik, 2011; Tunik et al., 2004;
Tunik et al., 2009). We postulate that our double-step design measures a much more
simplistic and direct automatic form of online visuomotor corrections. Finally, Desmurget et
al. (2004) only reported deficits in the online corrective system when target displacements
were evoked at hand movement onset, which posed the possibility for a confounding
influence of disease-related bradykinesia on PD performance. In this way, the cause of our
apparently discrepant results is clarified.
In contrast, when online feedback and motor control is investigated in the absence of
unpredictable effector perturbations and confounding disease pathology, a wide breath of
studies support our proposal that the basal ganglia are uninvolved in rapidly controlling
ongoing actions. First, using PET, Desmurget et al. (2001) failed to find changes in striatal
activity during double-step trials, which evoke automatic online guidance, relative to singlestep trials, which do not. Instead, metabolic changes in activity were restricted to the
contralateral PPC, contralateral motor cortex and ipsilateral anterior cerebellum during the
generation of corrective movements (Desmurget et al., 2001). Likewise, event-related fMRI
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designs have investigated the neural substrates involved in the planning and online control of
motor sequences and have found increased striatal activity exclusive to when the action is
being preprogramed or internally generated. Notably, no such increases in striatal activity
were reported during the online execution of motor sequences or during online sensory
feedback processing (Boecker et al., 2008; Elsinger et al., 2006; Ogawa et al., 2006).
Congruent with this, overwhelming evidence suggests that PD patients are in fact able to
continuously use sensory feedback during reaching or tracking movements (Bloxham et al.,
1984; Day et al., 1984; Flowers et al., 1976; Ghilardi et al., 2000).	
  Pertinent to our findings,
Johnson et al. (1994) also reported that exogenous dopamine medication had no effect on the
ability for PD patients to control their movements in an online visual tracking task. As first
alluded to by Desmurget et al. (2004), if the dorsal striatum is truly responsible for the online
processing of actions, then patients with PD should present with deficits in their ability to use
visual feedback in these tasks. Furthermore, increasing dopamine supplies to mediate dorsal
striatal function should improve performance in this domain. Our data, along with others,
contend that this is not the case. PD patients, regardless of dopaminergic medication status,
were consistently capable of using online feedback to update their internal representations of
goal positions and amend their actions appropriately in-flight. Taken together, the paucity of
reports of impaired online control in patients with basal ganglia abnormalities, in contrast
with the extensive documentation of other motor and cognitive deficits in PD and patients
with BG lesions (Jankovic, 2008; Kudlicka et al., 2011; Moustafa et al., 2016; Park & Stacy,
2009), could further be in support of our findings.
Several alternative roles have been suggested for the dorsal striatum in subserving
both motor and cognitive control. Under conditions in which dorsal striatal dopamine is
deplete, as prevalent in PD, deficits in decision making, specifically related to action
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selection and initiation in ambiguous contexts (Cools et al., 2006; Ell et al., 2006; Thoma et
al., 2008; Troyer et al., 2004) and attentional set shifting (Hayes et al., 1998; Hood et al.,
2007; Shook et al., 2005) are observed. Additionally, the dorsal striatum has been implicated
in reducing the distractibility of highly salient, yet task irrelevant stimuli (Benke et al., 2003;
Cools et al., 2006; Cools et al., 2010). For example, patients with PD are more likely to
attend to the more salient stimuli	
  among distractors and select the more automatic or wellpracticed response. Congruent with these results, the dorsal striatum is well-positioned
anatomically to integrate information from multiple modalities and broadly allocate attention
in space and time (MacDonald & Monchi, 2011). Consequently, when this region is impaired
attention becomes more narrowed and deliberate responses are harder to initiate over
responses that are over-learned or automatic. We suggest that because online reach
adjustments are highly automatized and can occur without volitional control, such
behavioural responses should not rely on intact dorsal striatal functioning.

4.5 Automaticity in Parkinson’s Disease
Rapid online reach corrections are an automatic default response that can occur in
healthy participants with and without conscious perceptual awareness or control. These
corrections provide a naturalistic and well-understood proxy for directly investigating
automaticity in an experimental setting. Our results clearly demonstrated that PD participants
were neither impaired during consciously perceived corrections nor during subliminally
presented automatic corrections, suggesting preservation of motor automaticity in PD.
Our results correspond well with those from oculomotor studies that suggest that PD
patients perform with the same, if not greater, automaticity than healthy controls (Chan et al.,
2005; Fielding et al., 2005; Praamstra et al., 2001). In addition, studies examining cognitive
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control have emphasized similar patterns of highly automated responses in PD participants
during assessments such as the Stroop task (Brown & Marsden, 1988; Djamshidian et al.,
2011; Dujardin et al., 1999). As discussed earlier, deficits in suppressing automatic response
mechanisms have been posited throughout the PD literature (Henik et al., 1993; Obeso et al.,
2011; Praamstra et al., 2001). If these trends hold true, we would speculate that PD would
also selectively impair higher-level volitional processes, such as inhibiting or
countermanding automatic online reach amendments. Such an outcome would further suggest
a relatively dominant level of automaticity in PD that mirrors that of healthy controls.
Ultimately, the disruption in inhibitory outputs from the basal ganglia would lead to
disinhibition of certain reflexive or impulsive orienting systems in PD. In theory this should
translate into a double dissociation between impaired volitional control and spared
automaticity in PD.

4.6 Limitations and Future Directions
Although our study is able to answer fundamental questions regarding the automatic
pilot in PD, we acknowledge that it contains inherent limitations. First, we must recognize
that our conclusion of intact online automatic action control in PD and our interpretations
that the basal ganglia are not involved in mediating this process rely on a null result. That is,
PD patients and controls, both on and off medication, performed statistically equivalent on all
of our critical measures. In response to this, we suggest that our results are not simply
attributable to a lack of statistical power, nor could features of our paradigm render it
insensitive to detect true differences. First, we showed that our experimental paradigm was in
fact capable of reliably detecting divergences in trajectories between stay and jump trials.
Divergence in reach trajectories became significantly apparent early-on in the action,
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suggesting that our functional data techniques were sensitive to slight changes in positioning.
Secondly, we used more than double the number of PD patients in our study than were used
in Desmurget et al.’s (2004) original design. Given that despite their small sample size,
Desmurget et al. (2004) still reported significant differences between healthy controls and PD
patients, we have confidence that our experiment was in fact powered significantly. Last and
most compelling, we had a total of 8 different replications in both the On medication session
and the Off medication session to find differences between PD and healthy controls if they
were indeed present. That is, we looked at 8 separate trajectories contrasting Condition (Jump
vs. Stay), Group (PD vs. Control) and Medication Status (On vs. Off). Importantly, in all
cases, there were no significant differences between PD patients and healthy controls, nor
were there significant effects across medication status. Nevertheless, the Condition variable
was significant for all comparisons. Further, the divergence started at similar time points for
these trials, with the small jumps having slightly later points of divergence and the large
jumps having slightly earlier points of divergence, with explanation for this difference
provided. Taken together, our high number of replications, larger sample size and sensitive
analyses provides us with confidence that our findings are not simply attributable to a Type 2
error.
Additionally, caution must be applied when interpreting our lack of dopaminergic
effects on online motor control. Given the absence of drug effects on all of our motor
variables our interpretation is limited. Whether our null finding surrounding dopaminergic
medication is due to the dopaminergic system itself not being involved in the automatic pilot
or because our task was insensitive to capture any On-Off medication differences remains
inconclusive. Increasing our power would improve the reliability and generalizability of
these results.
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Further, our investigation of automaticity in PD was restricted exclusively to online
corrections induced through the double-step paradigm. The double-step paradigm elicits
automatic corrections by inducing an unexpected spatial error between hand and target
position. In contrast, other studies have worked under the loose definition that an action is
automatic so long as it can be performed in the absence of cognitive resources (Doyon et al.,
1997; Faglioni, et al., 1995; Wylie et al., 2009). In this manner, automaticity can be
investigated by ‘over-training’ participants on a complex motor sequence and having the
habitually-learned sequence be performed simultaneously with a competing cognitive load.
Whether these tasks would encompass the same behaviors as automatic online corrections is
uncertain. To our knowledge, no study to date has investigated the similarities and/or
differences in the neural correlates and psychomotor demands between these two measures.
Presumably, it is critical to distinguish between different forms of automaticity before being
able to fully generalize our results.
Finally, we are unable to directly disconfirm the role of the basal ganglia in the
automatic corrective system, as this study was performed only at the behavioral level. It
would be necessary to integrate functional imaging into our design to investigate the exact
neural substrates involved in online corrections in individuals with PD.

4.7 Conclusions
PD is primarily recognized by its cardinal motor symptoms, including tremor, rigidity
and bradykinesia. Our results emphasize the importance of isolating the motor symptoms of
PD when investigating online motor control. This thesis argues that the previous work
examining online motor control was confounded by PD-related bradykinesia and
consequently led to the misinterpretation that patients with PD are also impaired in
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consciously mediated automatic online corrections. Our results suggest that PD neither
affects consciously mediated nor subliminal automaticity, as measured by the double-step
paradigm. Equalizing the preparatory phase and thus the task demands between groups
allowed PD patients to perform online corrections similar to those without basal ganglia
dysfunction. Additionally, we did not find any evidence for a role of the dopaminergic
system in the automatic pilot. We suggest that regions beyond the dopamine dependent
striatal loops are critical for mediating online motor guidance.
The outcomes from this study have several far-reaching implications. Our results
discredit the assumption that there is a dichotomy between conscious and subconscious
automatic online processing in PD. To this extent, our findings contribute to an improved
understanding of automaticity and online motor control in PD and help clarify previous
inconsistencies in the literature. Moreover, our results translate into a better appreciation for
the exact motor symptoms of PD and advise for further clarification into the role, if any, of
the basal ganglia in the online control of action.
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Appendices
Appendix A: Participant Inclusion/Exclusion Criteria
Healthy Controls

Patients with PD

No diagnosis of a movement disorder

Diagnosis of idiopathic PD from a licensed
clinical neurologist

No history of:

No history of the following unrelated to PD:

1. Neurological illness

1. Neurological illness

2. Psychiatric illness

2. Psychiatric illness

3. Neuro-trauma

3. Neuro-trauma

4. Psychosis or hallucinations

4. Psychosis or hallucinations

Normal or corrected-to-normal vision

Normal or corrected-to-normal vision

No previous participation in the study

No previous participation in the study

No history of substance abuse (ETOH,

No history of substance abuse (ETOH,

prescription medication, illicit drugs)

prescription medication, illicit drugs)

Not currently taking cognitive-enhancing

Not currently taking cognitive-enhancing

medications including:

medications including:

1. Donepezil

1. Donepezil

2. Galantamine

2. Galantamine

3. Rivastigimine

3. Rivastigimine

4. Memantine

4. Memantine

5. Methylphenidate

5. Methylphenidate
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No clinical diagnosis of dementia or mild

Responsive to dopaminergic medication

cognitive impairment
Currently prescribed and taking dopaminergic
medication
Disease duration < 15 years

No suspicion of familial form of PD (greater
than 2 first degree relatives with PD diagnosis)
No clinical diagnosis of dementia or mild
cognitive impairment
Must not have unstable or rapidly progressing
parkinsonism
No history of treatment of deep brain
stimulation or neurological surgery
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Appendix B: Consent Form
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Appendix C: Starkstein Apathy Scale
For	
  administrator’s	
  use	
  only	
   	
  
	
  
	
  
	
  
	
  
	
  
Score:	
   	
  
	
  
	
  
	
  

Date	
  (dd/mm/yy):	
  
Subject	
  #:	
  
	
  
Medication:	
   	
  

	
  
	
  

Session	
  #:	
  
Time:	
  

	
  

Starkstein	
  Apathy	
  Scale	
  
Instructions:	
  For	
  each	
  question,	
  indicate	
  as	
  “Not	
  at	
  all”,	
  “Slightly”,	
  “Some”,	
  or	
  “A	
  lot”	
  with	
  
an	
  ‘X’	
  while	
  leaving	
  the	
  other	
  spaces	
  blank.	
  
Questions	
  
1.	
  Are	
  you	
  interested	
  in	
  learning	
  
new	
  things?	
  
2.	
  Does	
  anything	
  interest	
  you?	
  
3.	
  Are	
  you	
  concerned	
  about	
  your	
  
condition?	
  
4.	
  Do	
  you	
  put	
  much	
  effort	
  into	
  
things?	
  
5.	
  Are	
  you	
  always	
  looking	
  for	
  
something	
  to	
  do?	
  
6.	
  Do	
  you	
  have	
  plans	
  and	
  goals	
  for	
  
the	
  future?	
  
7.	
  Do	
  you	
  have	
  motivation?	
  
	
  
8.	
  Do	
  you	
  have	
  the	
  energy	
  for	
  daily	
  
activities?	
  
9.	
  Does	
  someone	
  have	
  to	
  tell	
  you	
  
what	
  to	
  do	
  each	
  day?	
  
10.	
  Are	
  you	
  indifferent	
  to	
  things?	
  
11.	
  Are	
  you	
  unconcerned	
  with	
  many	
  
things?	
  
12.	
  Do	
  you	
  need	
  a	
  push	
  to	
  get	
  
started	
  on	
  things?	
  
13.	
  Are	
  you	
  neither	
  happy	
  nor	
  sad,	
  
just	
  in	
  between?	
  
14.	
  Would	
  you	
  consider	
  yourself	
  
apathetic?	
  

Not	
  at	
  all	
  

Slightly	
  

Some	
  

A	
  lot	
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Appendix D: Montreal Cognitive Assessment
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Appendix E: Montreal Cognitive Assessment Evaluation Scale
MoCA Version August 18, 2010 © Z. Nasreddine MD www.mocatest.org 1

Montreal Cognitive Assessment (MoCA)
Administration and Scoring Instructions
The Montreal Cognitive Assessment (MoCA) was designed as a rapid screening instrument for mild
cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive
functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and
orientation. Time to administer the MoCA is approximately 10 minutes. The total possible score is 30
points; a score of 26 or above is considered normal.
1. Alternating Trail Making:
Administration: The examiner instructs the subject: "Please draw a line, going from a number
to a letter in ascending order. Begin here [point to (1)] and draw a line from 1 then to A
then to 2 and so on. End here [point to (E)]."
Scoring: Allocate one point if the subject successfully draws the following pattern:
1 −A- 2- B- 3- C- 4- D- 5- E, without drawing any lines that cross. Any error that is not
immediately self-corrected earns a score of 0.
2. Visuoconstructional Skills (Cube):
Administration: The examiner gives the following instructions, pointing to the cube: “Copy this
drawing as accurately as you can, in the space below”.
Scoring: One point is allocated for a correctly executed drawing.
• Drawing must be three-dimensional
• All lines are drawn
• No line is added
• Lines are relatively parallel and their length is similar (rectangular prisms are accepted)
A point is not assigned if any of the above-criteria are not met.
3. Visuoconstructional Skills (Clock):
Administration: Indicate the right third of the space and give the following instructions: “Draw
a clock. Put in all the numbers and set the time to 10 past 11”.
Scoring: One point is allocated for each of the following three criteria:
• Contour (1 pt.): the clock face must be a circle with only minor distortion acceptable (e.g.,
slight imperfection on closing the circle);
• Numbers (1 pt.): all clock numbers must be present with no additional numbers; numbers
must be in the correct order and placed in the approximate quadrants on the clock face; Roman
numerals are acceptable; numbers can be placed outside the circle contour;
• Hands (1 pt.): there must be two hands jointly indicating the correct time; the hour hand must
be clearly shorter than the minute hand; hands must be centred within the clock face with their
junction close to the clock centre.
A point is not assigned for a given element if any of the above-criteria are not met.
MoCA Version August 18, 2010© Z. Nasreddine MD www.mocatest.org 2
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4. Naming:
Administration: Beginning on the left, point to each figure and say: “Tell me the name of this
animal”.
Scoring: One point each is given for the following responses: (1) lion (2) rhinoceros or rhino
(3) camel or dromedary.
5. Memory:
Administration: The examiner reads a list of 5 words at a rate of one per second, giving the following
instructions: “This is a memory test. I am going to read a list of words that you will have to

remember now and later on. Listen carefully. When I am through, tell me as many words as
you can remember. It doesn’t matter in what order you say them”.
Mark a check in the allocated space for each word the subject produces on this first trial. When
the subject indicates that (s)he has finished (has recalled all words), or can recall no more
words, read the list a second time with the following instructions: “I am going to read the same
list for a second time.Try to remember and tell me as many words as you can, including words you
said the first time.”
Put a check in the allocated space for each word the subject recalls after the second trial.
At the end of the second trial, inform the subject that (s)he will be asked to recall these words again
by saying, “I will ask you to recall those words again at the end of the test.”
Scoring: No points are given for Trials One and Two.
6. Attention: Forward Digit Span:
Administration: Give the following instruction: “I am going to say some numbers and when I am
through, repeat them to me exactly as I said them”. Read the five number sequence at a rate of one
digit per second.
Backward Digit Span:
Administration: Give the following instruction: “Now I am going to say some more numbers, but
when I am through you must repeat them to me in the backwards order.” Read the three number
sequence at a rate of one digit per second.
Scoring: Allocate one point for each sequence correctly repeated, (N.B.: the correct response for the
backwards trial is 2-4-7).
Vigilance:
Administration: The examiner reads the list of letters at a rate of one per second, after giving the
following instruction: “I am going to read a sequence of letters. Every time I
say the letter A, tap your hand once. If I say a different letter, do not tap your hand”.
Scoring: Give one point if there is zero to one errors (an error is a tap on a wrong letter or a
failure to tap on letter A).
MoCA Version August 18, 2010 © Z. Nasreddine MD www.mocatest.org 3
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Administration: The examiner gives the following instruction: “Now, I will ask you to count by
subtracting seven from 100, and then, keep subtracting seven from your answer until I tell you to
stop.” Give this instruction twice if necessary.
Scoring: This item is scored out of 3 points. Give no (0) points for no correct subtractions, 1 point for
one correction subtraction, 2 points for two-to-three correct subtractions, and 3 points if the
participant successfully makes four or five correct subtractions. Count each correct subtraction of 7
beginning at 100. Each subtraction is evaluated independently; that is, if the participant responds with
an incorrect number but continues to correctly subtract 7 from it, give a point for each correct
subtraction. For example, a participant may respond “92 – 85 – 78 – 71
– 64” where the “92” is incorrect, but all subsequent numbers are subtracted correctly. This is one
error and the item would be given a score of 3.
7. Sentence Repetition:
Administration: The examiner gives the following instructions: “I am going to read you a sentence.
Repeat it after me, exactly as I say it [pause]: I only know that John is the one to help today.”
Following the response, say: “Now I am going to read you another sentence.Repeat it after me,
exactly as I say it [pause]: The cat always hid under the couch when dogs were in the room.”
Scoring: Allocate 1 point for each sentence correctly repeated. Repetition must be exact. Be alert for
errors that are omissions (e.g., omitting "only", "always") and substitutions/additions
(e.g., "John is the one who helped today;" substituting "hides" for "hid", altering plurals, etc.).
8. Verbal fluency:
Administration: The examiner gives the following instruction: “Tell me as many words as you can
think of that begin with a certain letter of the alphabet that I will tell you in a moment. You can say
any kind of word you want, except for proper nouns (like Bob or Boston), numbers, or words that
begin with the same sound but have a different suffix, for example, love, lover, loving. I will tell you to
stop after one minute. Are you ready? [Pause] Now, tell me as many words as you can think of that
begin with the letter F. [time for 60 sec]. Stop.”
Scoring: Allocate one point if the subject generates 11 words or more in 60 sec. Record the subject’s
response in the bottom or side margins.
9. Abstraction:
Administration: The examiner asks the subject to explain what each pair of words has in common,
starting with the example: “Tell me how an orange and a banana are alike”. If the subject answers in
a concrete manner, then say only one additional time: “Tell me another way in which those items are
alike”. If the subject does not give the appropriate response (fruit), say, “Yes, and they are also both
fruit.” Do not give any additional instructions or clarification. After the practice trial, say: “Now, tell
me how a train and a bicycle are alike”. Following the response, administer the second trial, saying:
“Now tell me how a ruler and a watch are alike”.
Do not give any additional instructions or prompts.
MoCA Version August 18, 2010 © Z. Nasreddine MD www.mocatest.org 4

Scoring: Only the last two item pairs are scored. Give 1 point to each item pair correctly answered.
The following responses are acceptable:
Train-bicycle = means of transportation, means of travelling, you take trips in both;
Ruler-watch
= measuring instruments, used to measure.
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The following responses are not acceptable: Train-bicycle = they have wheels; Ruler-watch
= they have numbers.
10. Delayed recall:
Administration: The examiner gives the following instruction: “I read some words to you
earlier, which I asked you to remember. Tell me as many of those words as you can
remember.” Make a check mark for each of the words correctly recalled spontaneously
without any cues, in the allocated space.
Scoring: Allocate 1 point for each word recalled freely without any cues.
Optional: Following the delayed free recall trial, prompt the subject with the semantic category cue
provided below for any word not recalled. Make a check mark ( √ ) in the allocated space if the
subject remembered the word with the help of a category or multiple-choice cue. Prompt all nonrecalled words in this manner. If the subject does not recall the word after the category cue, give
him/her a multiple choice trial, using the following example instruction, “Which of the following
words do you think it was, NOSE, FACE, or HAND?”
Use the following category and/or multiple-choice cues for each word, when appropriate:
FACE: category cue: part of the body multiple choice: nose, face, hand
VELVET: category cue: type of fabric multiple choice: denim, cotton, velvet
CHURCH: category cue: type of building multiple choice: church, school, hospital
DAISY: category cue: type of flower multiple choice: rose, daisy, tulip
RED: category cue: a colour multiple choice: red, blue, green
Scoring: No points are allocated for words recalled with a cue. A cue is used for clinical
information purposes only and can give the test interpreter additional information about the type of
memory disorder. For memory deficits due to retrieval failures, performance can be improved with a
cue. For memory deficits due to encoding failures, performance does not improve with a cue.
11. Orientation:
Administration: The examiner gives the following instructions: “Tell me the date today”. If the
subject does not give a complete answer, then prompt accordingly by saying: “Tell me the
[year, month, exact date, and day of the week].” Then say: “Now, tell me the name of this place, and
which city it is in.”
Scoring: Give one point for each item correctly answered. The subject must tell the exact date and the
exact place (name of hospital, clinic, office). No points are allocated if subject makes an error of one
day for the day and date.
TOTAL SCORE: Sum all sub-scores listed on the right-hand side. Add one point for an
individual who has 12 years or fewer of formal education, for a possible maximum of 30 points.
A final total score of 26 and above is considered normal.
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Appendix F: Bond & Lader Mood Scale
For	
  administrator’s	
  use	
  only	
   	
  
	
  
	
  
	
  
	
  
	
  
Score:	
   	
  
	
  
	
  
	
  

Date	
  (dd/mm/yy):	
  
Subject	
  #:	
  
	
  
Medication:	
   	
  

	
  

	
  
Bond	
  &	
  Lader	
  Visual	
  Analogue	
  Mood	
  Scale	
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Session	
  #:	
  
Time:	
  

	
  

Appendix G: ANART
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Appendix H: Health and Demographic Questionnaire
Please	
  print	
  and	
  fill	
  out	
  this	
  form	
  as	
  accurately	
  as	
  possible	
  and	
  bring	
  it	
  with	
  you	
  to	
  your	
  first	
  
appointment	
  session.	
  If	
  you	
  are	
  attending	
  your	
  appointment	
  with	
  another	
  participant,	
  please	
  ensure	
  
you	
  both	
  have	
  your	
  own	
  personal	
  copies	
  filled	
  out.	
  
1.	
  Basic	
  Demographic	
  Information	
  
Date	
  of	
  Birth:	
  _____________________________	
  

	
  

Age:	
  _______	
  

Weight:	
  _________________	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   Height:	
  ___________	
  
Sex:	
  _______	
   	
  

	
  

	
  

First	
  language:	
  __________________	
  

	
  

	
  

	
  

Handedness:	
  _____________	
  

Other	
  languages:	
  ___________________________	
  

Level	
  of	
  Education	
  and	
  total	
  years	
  (e.g.	
  4	
  years	
  high	
  school,	
  4	
  years	
  university,	
  etc.)	
  
______________________________________________________________________________	
  
Occupation:	
  ______________________________	
  
2.	
  Health-‐Related	
  Information	
  
A.	
  Smoking	
  History	
  (please	
  circle):	
  

Never	
  Smoker	
   	
  

Ex-‐Smoker	
  

Current	
  Smoker	
  

If	
  current	
  smoker,	
  indicate	
  how	
  many	
  years	
  and	
  how	
  many	
  cig/day:	
  _______________________	
  
If	
  ex-‐smoker,	
  indicate	
  year	
  that	
  you	
  quit;	
  how	
  many	
  years	
  smoking;	
  how	
  many	
  cig/day:	
  
______________________________________________________________________________	
  
B.	
  Alcohol	
  History	
  
Average	
  number	
  of	
  drinks	
  per	
  week:	
  _____________	
  
Has	
  there	
  ever	
  been	
  heavy	
  alcohol	
  consumption?	
  (please	
  circle)	
  Yes	
  

No	
  

If	
  yes,	
  when,	
  for	
  how	
  long,	
  and	
  estimate	
  your	
  weekly	
  alcohol	
  consumption	
  during	
  that	
  time:	
  
______________________________________________________________________________	
  
C.	
  Other	
  Drug	
  History	
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Have	
  you	
  ever	
  taken	
  street	
  drugs	
  or	
  other	
  drugs	
  that	
  were	
  not	
  prescribed	
  by	
  a	
  physician	
  (please	
  
circle)?	
   	
  

Yes	
  

No	
  

If	
  yes,	
  when,	
  what	
  drugs,	
  how	
  frequently	
  and	
  over	
  what	
  period	
  of	
  time?	
  
______________________________________________________________________________	
  
D.	
  Eye	
  Glasses	
  (only	
  if	
  applicable)	
  
What	
  is	
  the	
  prescription	
  of	
  your	
  eye	
  glasses?	
  ______________	
  
Without	
  the	
  aid	
  of	
  glasses	
  are	
  you	
  able	
  to	
  see	
  near	
  objects	
  well	
  (please	
  circle)?	
   Yes	
  

No	
  

Without	
  the	
  aid	
  of	
  glasses	
  are	
  you	
  able	
  to	
  see	
  far	
  objects	
  well	
  (please	
  circle)?	
  

No	
  

Yes	
  

E.	
  Parkinson’s	
  Disease	
  (only	
  if	
  applicable)	
  
What	
  year	
  were	
  you	
  diagnosed	
  with	
  Parkinson’s	
  disease?	
  _________________	
  
Which	
  side	
  of	
  the	
  body	
  is	
  more	
  affected?	
  _________________	
  
3.	
  Previous	
  Medical	
  Problems	
  
Have	
  you	
  had	
  any	
  major	
  health	
  problems	
  or	
  do	
  you	
  have	
  any	
  chronic,	
  ongoing	
  medical	
  conditions	
  
such	
  as	
  high	
  blood	
  pressure,	
  high	
  cholesterol,	
  diabetes,	
  thyroid	
  problems,	
  multiple	
  sclerosis	
  or	
  
epilepsy?	
  	
  Have	
  you	
  had	
  any	
  strokes,	
  heart	
  attacks/	
  heart	
  surgeries,	
  significant	
  head	
  trauma,	
  or	
  
cancer?	
  	
  If	
  you've	
  had	
  cancer,	
  what	
  kind	
  and	
  what	
  treatments	
  did	
  you	
  receive	
  (e.g.	
  chemotherapy)?	
  
Have	
  you	
  ever	
  had	
  more	
  than	
  one	
  seizure?	
  Answer	
  in	
  the	
  space	
  below.	
  
	
  
4.	
  Family	
  Medical	
  Problems	
  
Is	
  there	
  anyone	
  in	
  your	
  family	
  with	
  a	
  neurological	
  or	
  serious	
  psychiatric	
  illness	
  such	
  as	
  PD,	
  
Huntington's,	
  epilepsy,	
  strokes	
  at	
  a	
  young	
  age	
  (<	
  50	
  for	
  men	
  and	
  <	
  60	
  for	
  women)?	
  	
  Is	
  there	
  anyone	
  
who	
  had	
  trouble	
  walking	
  or	
  with	
  balance,	
  needing	
  a	
  wheelchair	
  or	
  a	
  walker	
  at	
  a	
  young	
  age?	
  	
  Any	
  
family	
  members	
  with	
  dementia	
  (such	
  as	
  Alzheimer's),	
  schizophrenia,	
  bipolar/manic	
  depression,	
  or	
  
severe	
  depression	
  or	
  anxiety	
  requiring	
  hospitalization	
  or	
  close	
  follow	
  up	
  by	
  a	
  psychiatrist?	
  Answer	
  in	
  
the	
  space	
  below.	
  
5.	
  Current	
  Medication	
  
Please	
  list	
  any	
  medications	
  you	
  are	
  currently	
  taking,	
  what	
  they	
  are	
  treating	
  for	
  specifically,	
  and	
  the	
  
prescribed	
  dosage.	
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Appendix I: Levodopa Screening Questionnaire
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Appendix J: UPDRS Protocol
UPDRS Protocol
Ask at the start “which arm/hand do you have most difficulty with?”
Always start with LESS impaired side
Only model for a few seconds, then stop
“This is subject (PD/CTRL #), session #, (on/off) medication.”
1. Film face at rest for a few seconds
2. Ask patient to speak one-two sentences (for dysarthria)
•

“Today is a very nice day outside”

•

“I am at the University for an experiment”

3. Evaluate resting tremor
a. hands relaxed on thighs
b. with cognitive stressing “Close your eyes and name the months of the year
backward from December”
4. Evaluate tone
a. Bilateral upper extremities
5. Evaluate postural tremor
a. hands outstretched
b. fingertips apposed (forming wings with arms ensuring fingers are not
touching)
6. Evaluate action tremor
a. Finger-to-nose (finger target should be arms-length away and in same
position)
7. Evaluate bradykinesia
a. Finger taps (pinching) “Big and fast”
b. Hand opening-closing movements “Big and fast”
c. Pronation-supination movements “Fast as you can”
d. Toe-tapping (minimum 3 inches off ground)
8. Ask patient to rise from the chair without the assistance of his/her arms (arms crossed
over chest) “Fold your arms across and chest and stand up”
	
  

9. Evaluate gait, ask to walk up and down hallway 2-3 times, with turns

110	
  

	
  

10. Pull test “Try to maintain your balance and limit yourself to one step backwards”
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Appendix K: Ethics Approval
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